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Summary
Recent evidence has indicated that adenosine, in 
addition to potassium and calcium currents, may also 
affect chloride movement in hippocampal neurones. This 
project was undertaken to determine the possible role of 
adenosine on chloride channels and synaptic plasticity in 
comparison with a selective GABAA agonist, muscimol.
Extracellular recordings were made from the CA1 
pyramidal cell layer of hippocampal slices in response to 
stimulation of Schaffer collateral fibres in stratum 
radiatum (0.01 Hz). Adenosine and muscimol induced 
concentration dependent reductions in the amplitude of 
orthodromically induced population potentials. In order 
to eliminate effects of these agents on potassium 
channels, experiments were performed in the presence of 
barium, ImM (in some experiments in the presence of 1 mM 
tolbutamide). This concentration increased potential 
size, and reduced the inhibitory effect of adenosine on 
population spike size, but not synaptic potential size. 
This profile is consistent with the blockade of potassium 
channels associated only with the postsynaptic effects of 
adenosine. However, muscimol responses were unaffected. 
Adenosine potentiated the ability of muscimol to inhibit
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evoked potentials in the absence or presence of barium. 
The potentiation was prevented by the Aj selective 
antagonist 8 -cyclopentyltheophyl1ine. The effects of 
adenosine, as well as muscimol, were reduced by the 
chloride channel blocker DIDS, which also prevented the 
adenosine potentiation of muscimol. The results indicate 
the ability of adenosine to operate chloride channels in 
hippocampal neurones, and suggest a potentiative 
interaction between adenosine and muscimol which also 
involve chloride channels.
The second part of this study was to examine 
neurosteroids which have been reported to be positive 
modulators of the GABAA receptors. Alphaxalone and 5a- 
pregnan-3a-ol-20-one potentiated the inhibitory effect of 
muscimol on the population spike size at low 
concentrations (0.5 and 1 pM) that had no significant 
effect on the spike size by themselves. This profile is 
in agreement with other reports which have described the 
effect of these neurosteroids as barbiturate-like. 
Alphaxalone and 5a-pregnan-3a-ol-20-one also at low 
concentrations potentiated the inhibitory effect of 
adenosine alone and in the presence of barium 1 mM which 
blocked adenosine activated potassium channels. 
Alphaxalone failed to potentiate the inhibitory effect of 
adenosine in the presence of bicuculline 1 pM. It is
XII
concluded that these neurosteroids enhanced the 
potentiative interaction between adenosine and muscimol 
in the presence of barium. The results indicate that 
adenosine’s effects are normally enhanced by virtue of 
the potentiative interaction occurring with endogenous 
GABA. In addition to this, the results show the chloride 
channels activated by adenosine to be different from 
those operated by the GABAA receptor.
The third part of this project was to investigate 
the role of GABAA and adenosine receptors on long-term 
depression (LTD) and synaptic plasticity. Unlike long­
term potentiation, LTD in the central nervous system 
remains poorly understood. Muscimol induced a time and 
concentration-dependent LTD in the amplitude of 
orthodromic potentials. Increasing the stimulation 
frequency from 0.01 Hz to 1 Hz for 10 seconds reversed 
the LTD induced by muscimol. Although adenosine decreased 
the spike size in a concentration-dependent manner, it 
failed to induce LTD. Muscimol also induced LTD in the 
absence of electrical stimulation.
Alphaxalone and 5a-pregnan-3a-ol-20-one at 
concentrations that did not have any effect themselves on 
the population spike (0.5 and 1 pM), potentiated the 
inhibitory effect of muscimol on the population spike
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size. These neurosteroids at high concentrations (5 and 
10 pM) decreased the spike size by themselves. On the 
other hand, at the low concentrations both steroids were 
able to potentiate the ability of muscimol to induce LTD. 
Moreover, muscimol 1 pM which is not able to induce LTD, 
alphaxalone and 5a-pregnan-3a-ol-20-one 1 pM maintained 
the LTD induced by muscimol 10 pM. Bicuculline 5 pM 
reversed the LTD induced by muscimol 10 pM. To examine 
the possible role of glutamate receptors in LTD induced 
by muscimol a number of NMDA and metabotropic receptors 
agonists and antagonists were used. The NMDA receptor 
antagonist 2-AP5, the NMDA/metabotropic antagonist 2-AP3 
and selective metabotropic antagonist L(+)-AP3 failed to 
modify the LTD. Quisqualic acid and (1S,3R)- 
aminocyclopentane dicarboxylic acid (ACPD), a selective 
agonist at metabotropic receptors, did not induce LTD or 
short-term depression, whereas kynurenic acid prevented 
the reversal of the LTD obtained at 1 Hz. It is concluded 
that LTD can be induced by the selective activation of 
GABAa receptors and the lack of involvement of glutamate 
receptors in the protocol which is presented in this 
study confirms the unique role of classical GABAA 
receptors in the effect of muscimol and may indicate a 
novel type of long-lasting depression. Furthermore, the 
failure of adenosine to induce LTD taken together with
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the earlier results, suggests that the adenosine 
activated chloride channel differs from the GABAA receptor 
chloride channel.
The last part of this study investigated the role of 
calcium in the induction of LTD and the mechanism of 
reversal of muscimol induced LTD. It was observed that 
the LTD can be obtained in the absence of calcium. In 
addition to this, the LTD was reversed by NMDA, kainic 
acid, high potassium medium, veratrine and calcium 
ionophore but not high calcium medium. Interestingly, 
high potassium medium in the absence of calcium reversed 
the LTD induced by muscimol 10 pM. The results suggest 
that this type of LTD can be induced in the absence of 
calcium and reversal of the LTD is due to a simple 
depolarization, as a result of sodium influx. These 
results emphasise the novelty of the muscimol-induced 
LTD, described here for the first time.
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INTRODUCTION
1. Introduction
During the last 20 years, there has been intensive 
research into the neuromodulator adenosine. Adenosine 
receptors have been classified and their distribution and 
function thoroughly examined in the mammalian brain. 
Adenosine has been shown to modulate neuronal function in 
the central nervous system through a variety of receptor- 
mediated mechanisms including second messenger systems, ion 
fluxes and modulation of transmitter release. However, the 
mechanism of adenosine action on ion fluxes is still not 
well understood. This thesis will look at the possible role 
of adenosine on chloride channels in comparison with a 
selective GABAA agonist, muscimol and their role in synaptic 
plasticity.
1.1. Adenosine - an historical overview
The potent extracellular actions of adenosine and ATP 
were first reported by Dury and Szent-Gyorgyi (1929). In 
1954 Holton and Holton reported that the ATP might 
represent the vasodilatory substance that was released upon 
antidromic stimulation of sensory nerves supplying the 
rabbit ear artery. The current interest in adenosine began 
with the realization of its potent inhibitory properties on
1
neurones. In 1970 Sattin and Rail showed that adenosine 
could stimulate cAMP formation in brain, while caffeine 
could antagonise this response. The inhibitory effect of 
adenosine in various regions of the brain was shown by 
Kostopoulos and Phillis (1977). Burnstock proposed a basis 
for distinguishing two types of purinoceptors, termed Pj for 
the nucleoside receptor (e.g. adenosine) and P2 for the 
nucleotide receptor (e.g. ATP)(Burnstock, 1978). This 
classification was mainly based on the relative potencies 
of ATP, ADP, and adenosine, the selective action of 
antagonists, in particular methylxanthines, and modulation 
of adenylate cyclase by adenosine, but not ATP. It 
subsequently became apparent that adenosine receptors could 
be classified into subtypes (Aj and A2) primarily 
characterized by their ability to affect adenylate cyclase 
activity (Van Calker et al. , 1979). In addition to this,
more recently, Aj and A^  receptor subtypes have also been 
identified by cloning (Zhou et al. , 1992) and binding
studies (Cronfield et al., 1992).
1.2 Biosynthesis, release and inactivation of adenosine
Adenosine is known to be released in a calcium- 
dependent fashion from nerve terminals following nerve 
stimulation (Stone, 1989). This could be derived from
2
intracellular adenosine formed by the action of cytosolic 
5’-nucleotidase or S-adenosylhomocysteine hydrolase 
(Snyder, 1985). Adenosine can also be synthesized de novo 
from phosphoribosyl-l-pyrophosphate glutamine (Stone and 
Simmonds, 1991). Release of adenosine appears to be 
dependent on the metabolic status of the tissue, reflecting 
the role of adenosine in regulating energy homeostasis 
within the CNS (Meghji, 1991).
Electrical stimulation can release adenosine from 
brain sliced (Sciotti et al. , 1992). In addition to this,
the concentration of adenosine can rise several hundred 
fold during metabolic seizures (During and Spencer, 1992), 
hypoxia (Rehncrona et al., 1978) or ischemia (Winn et al., 
1981) and also by depolarisation with glutamate (Hoehn and 
White, 1990).
Adenosine is inactivated by adenosine uptake mechanisms 
and via break down to inosine by adenosine deaminase or 
phosphorylation to AMP by adenosine Kinase (Meghji, 
1991,1993). It should be noted that the uptake system plays 
a key role in the inactivation of adenosine.
Although adenosine can be taken up by uptake mechanisms 
and released following depolarisation, unlike endocrine 
hormones it is not specifically produced by particular
3
cells or tissues, and unlike classical neurotransmitters it 
is not stored and released from particular neurones that 
form specific pathways.
1.3 Adenosine receptors
1.3.1 Classification and distribution
Adenosine receptors have been classified according to 
their action on adenylate cyclase (Van Calker et al. , 
1979) , adenosine Aj-receptors having an inhibitory and Aja 
stimulatory action. Although it has been shown that 
adenosine can act via cyclic adenosine monophosphate- 
independent mechanisms (Dunwiddie and Hoffer, 1980), the 
Aj/Aj-classification has been useful.
Aj-receptors have been thoroughly studied, since 
numerous ligands are available that have high affinity for 
this receptor and satisfactory specificity. Aj-receptors 
have been described as mediating the modulatory action of 
adenosine on neuronal activity, and autoradiographic 
studies have demonstrated the highly specific distribution 
of this receptor subtype. In the rat brain, areas of high 
concentration of Aj binding sites include the molecular 
layer of the cerebellum, dendritic zones of hippocampus, 
the medial and lateral nuclei of the thalamus, the lateral
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septum and medial geniculate body (Lewis et al., 1981;
Goodman and Synder, 1982; Erfurth and Reddington, 1986). 
The distinct distribution of Aj-receptors has been confirmed 
in studies of post mortem human brain tissue (Fastbom et 
al., 1987; Deckert et al. , 1993). The results of Deckert
and Jorgensen (1988), showing that adenosine Aj receptors 
are located presynaptically and postsynaptically, are more 
consistent with the electrophysiological studies of 
Thompson et al. , (1992) that adenosine acts at pre- and
postsynaptic receptors which are pharmacologically 
indist inguishable.
Studying the A2~receptor has been more difficult due to 
the lack of specific A 2 agonists and antagonists. In order 
to differentiate between the stimulatory effects of 
adenosine in striatum and cortex, a subclassification of A2~ 
receptors into A2a and A^ subtypes has been suggested. This 
classification is based on [ H]NECA binding, high and low 
affinity respectively for A2a and A^ (Bruns at al., 1986). 
It should be noted that both these subtypes increase 
adenylate cyclase activity.
Autoradiographic techniques have so far only allowed 
the detection of the A2a subtype, suggesting that these two 
subtypes exhibit different molecular properties in the
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brain (Reddington and Lee, 1991). In rat (Reddington et 
al. , 1986) and also in human brain (Martinez-Mir et al. ,
1991), A 2a~receptors have been described as being 
specifically located in striatum, nucleus accumbens and 
olfactory tubercle.
In addition to an action at extracellular adenosine 
receptors, adenosine can inhibit adenylate cyclase by 
interacting with an intracellular P-site, that appears to 
be located oh the catalytic subunit of adenylate cyclase 
(Londos and Wolff. 1977). The P site has a low affinity for 
adenosine, in the high micromolar range, and is not blocked 
by adenosine receptor antagonists. Moreover, some adenosine 
derivatives, e.g. dideoxyadenosine, are selectively active 
at the P-site. The physiological role of the P-site is 
still unknown.
Recently, a third class of adenosine receptors (A3) has 
been cloned from rat brain (Zhou et al., 1992).It has been 
shown that this Aj receptor is coupled to a pertussis toxin- 
sensitive G protein. Furthermore, like A| receptors, Aj 
receptors are coupled to both the inhibition of adenylate 
cyclase (Zohu et al., 1992) and the stimulation of inositol 
phosphate metabolism (Beaven et al. , 1994). The Aj receptors 
are insensitive to xanthines (Carruthers and Fozard, 1993) .
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Activation of A 3 receptors is associated with hypotensive, 
behavioral and cardioprotective effects and an anti 
inflammatory action (Fozard and Carruthers, 1993; Jacobson 
et al., 1993a,b; Liu et al. , 1994).
1.3.2 Ligands for adenosine receptors
The chemical synthesis efforts made over several years 
have aimed to improve the potency and selectivity of 
adenosine analogs for either the Aj or A 2 receptor (Williams 
et al. , 1986; Williams and Cusack, 1990). There has been
less success in developing A2^ and A 3 ligands compared with 
the Aj receptor. Thus, the functional role of the A2j and A 3 
receptors is still largely unknown.
Most structural modifications were related to N®- 
substituted adenosine derivatives which showed selectivity, 
high affinity and potency at Aj receptor sites (Williams et 
al., 1986; Williams, 1987). Conversely, chemical
substitution on C2 of either adenosine itself or 5 *-N- 
ethylcarboxamidoadenosine (NECA) have led to a variety of 
compounds displaying A2a agonist properties. Among them, the
2-alkynyladenosine and 2-alkynyl-NECA derivatives appear to 
be relatively potent at A2a receptors and some of them show 
good A2a vs Aj selectivity. CGS 21680 has recently been
presented as a selective A2a receptor agonist with 70-140 
fold selectivity for this receptor in binding assays 
(Williams, 1991). To date for the A 3 receptor N6-2-(4- 
aminophenyl)ethyladenosine (APNEA) is used as non-selective 
agonist (Fozard and Carruthers, 1993) and N®-(3- 
iodobenzyl)5’- (N-methylcarbamoyl)adenosine (IB-MECA) as a 
selective agonist which is 50-fold selective in binding 
assays for rat brain A 3 vs either Aj or A2a receptors (Gallo- 
Rodriguez et al. , 1994). The potency profile of these
adenosine analogs at adenosine receptors in a variety of 
tissue is as follows:
Aj: CPA>R-PIA=CHA>NECA>2CADO>S-PIA
A2a: CGS21680=NECA>2CADO>R-PIA=CHA=CPA>S-PIA
A2jj: NECA>2CADO>R-PIA=CHA>S-PIA>CGS21680
A3: IB-MECA>APENEA>R-PIA=NECA>CGS21680 (Collis and Hourani, 
1993; Dalziel and Westfall, 1994).
For investigating the functions of adenosine receptors 
antagonists have also been used. In addition to caffeine 
and theophylline, which have marked phosphodiesterase 
inhibitory activity, more selective and more potent 
adenosine receptor antagonists have been developed. For 
example, 8 -phenyltheophylline is more potent than 
theophylline at blocking the Aj receptor. Indeed,
theophylline and caffeine are not able to discriminate 
between and A 2 adenosine receptors (Daly et al. , 1981;
Fredholm and Persson, 1982). 8 -cyclopenty1-
1.3,dipropylxanthine (DPCPX) and cyclopentyltheophyl1ine 
(CPT) show 740 and 130-fold selectivity for the Aj receptor 
respectively (Williams, 1991). However, there is technical 
limitation to the use of DPCPX because of its low 
solubility.
8 -(3-chlorostyryl) Caffeine (CSC) shows 520-fold
selectivity for the A2a receptor, whereas there is no 
selective A2^ adenosine receptor antagonist (Jacobson et 
al., 1993a). Fozard and Hanon have recently reported that
3- (3-1odo-4-aminobenzyl)-8 -(4-oxyacetate)-1-propylxanthine 
(BW-A522) blocks the adenosine A 3 receptor (Fozard and 
Hanon, 1994) .
1.3.3. Functional effects of adenosine receptors
The Aj and A 2 receptors mediate somewhat different
effects in most tissues. The Aj receptor has an inhibitory 
effect on nerve terminals and mediates negative inotropic
effects on the heart. The A 2 receptor shows vasodilatory
effects on vessels (Stone, 1991). There is debate
concerning the inhibitory or stimulatory effect of A 2
receptors in CNS. The A 2 selective adenosine receptor 
agonist CGS21680 depressed the spontaneous, acetylcholine- 
and glutamate-evoked firing of rat cerebral sensorimotor 
cortical neurons (Phillis, 1990). In rat hippocampal 
slices, CGS21680 decreased the EPSP size in CA1. This A 2 
agonist did not increase cAMP levels in the hippocampus but 
in the striatum it enhanced cAMP levels two fold. 
Therefore, it may act at an Aj adenosine receptor in the 
hippocampus to show the inhibitory effect (Lupica et al.,
1990). It has been shown that 2 pM NECA, which activates 
both Aj and A 2 receptors, increased glutamate release 
slightly in pyramidal cells of hippocampal cultures 
(Prestwich et al. , 1987). By intracellular recording in rat 
hippocampus, Ameri and Jurna (1991) also demonstrated that 
R-PIA and NECA at high concentration affected membrane 
properties and showed excitatory effects. Theophylline 
blocked this effect but DPCPX, an Aj antagonist, was 
ineffect ive.
1.3.4. Presynaptic effects
Aj-receptors mediate both presynaptic and postsynaptic 
events in the CNS. Adenosine decreases the release of 
several neurotransmitters, including acetylcholine ((Dun&r- 
Engstrom and Fredholm, 1988; Fredholm, 1990a,b), dopamine
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(Lupica et al., 1990), noradrenaline (Allgaier et al.,
1987; Jonzon and Fredholm, 1984), serotonin (Feuerstein et 
al., 1988), GABA (Hollins and Stone, 1980) and glutamate
(Dolphin and Archer, 1983; Prestwich et al., 1987).
However, it should be noted that most reports show the 
inhibitory action of adenosine on excitatory rather 
inhibitory neurotransmitters (Hu and Fredholm , 1989). This 
may be consistent with the idea that adenosine receptors 
are located on excitatory terminals (Lambert and Teylor, 
1991; Yoon and Rothman, 1991; Thompson et al., 1992).
Transmitter release is dependent on calcium influx 
into nerve terminals, and one possible mechanism of action 
of adenosine to inhibit transmitter release may be 
blocking of the calcium influx. In rat brain synaptosomal 
preparations, adenosine modulated calcium uptake by 
potassium (Wu et al., 1982) or veratridine-depolarized
nerve terminals (Michaelis et al., 1988) through an action 
on extracellularly localized adenosine receptors. Adenosine 
analogues decreased calcium uptake across voltage sensitive 
calcium channels slightly in both synaptosomes and 
hippocampal slices (Bartrup, 1989) . By contrast, adenosine 
and adenosine analogs had no effect on calcium uptake by 
potassium-depolarisation (Barr et al. , 1985; Garritsen et
al., 1989) and veratridine stimulation (Garritsen et al.,
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1989). The lack of effect of adenosine or its analogs in
the Barr and Garritsen reports could be that adenosine
2+receptors which control Ca uptake are present only in a 
subset of the synaptosomes or adenosine affects the 
sensitivity for calcium rather than the calcium 
concentration in the neuronal cell. With ion sensitive 
microelectrodes adenosine decreased pre- and postsynaptic 
calcium signals of rat hippocampal cells in low calcium 
medium (Schubert et al., 1986). 4-aminopyridine could not 
prevent the inhibition of calcium influx by adenosine. 
Organic calcium blockers (verapamil and nifedipine) blocked 
postsynaptic calcium entry not presynaptic. Thus adenosine 
may depress calcium current at presynaptic nerve terminals 
by transient calcium channels (T or N)(Schubert et al.,
1986). In another report Schubert (1988) showed that 
endogenous adenosine, via Aj receptors, inhibits calcium 
influx. Silinsky (1986) proposed adenosine impairs 
transmitter secretion by reducing the affinity for calcium 
at a site beyond the external orifice of the calcium 
channel. Adenosine-evoked inhibition of calcium current may 
have resulted from a shunt of the calcium current secondary 
to the adenosine-evoked increase in potassium currents 
(Gerber et al., 1989 ; Greene and Haas, 1989).
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1.3.5. Postsynaptic action
The anticonvulsant action of adenosine has been 
described as a postsynaptic event which is mediated by A| 
receptor. Postsynaptic mechanisms comprise activation of 
potassium channels and the control of calcium fluxes. 
However, the type of potassium channel activated by 
adenosine is still a matter of controversy.
Adenosine in cultured postganglionic neurones of avian 
ciliary ganglia under whole-cell voltage clamp blocked 
calcium-activated potassium channels (Bennett et al.,
1991). Furthermore, adenosine hyperpolarised CA1 neurones 
and decreased input resistance in normal and low calcium 
medium. Adenosine also suppressed excitatory postsynaptic 
potentials (EPSP), by a presynaptic effect, without any 
effect on resting membrane potential (Segal , 1982). Okada 
and Ozawa (1981) also showed a hyperpolarisation action of 
adenosine in the hippocampus.
In single voltage clamp, adenosine evoked or increased 
three potassium conductances: l)dependent on calcium and
voltage, 2 )dependent on calcium only and 3)insensitive to 
both and not inwardly rectifying (Haas and Greene, 1988). 
Adenosine at low concentration (10 p,M) increased the after-
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hyperpolarisation (AHP) induced by a burst of action 
potentials with no effect or little effect on the resting 
membrane potential (RMP). Increasing the concentration of 
adenosine to 50 pM often decreased AHP and input 
resistance. Tetraethylammonium (TEA), a blocker of delayed 
outward rectification, and 4AP (blocker of transient 
outward rectification) had no effect on adenosine action 
(Greene and Haas, 1985; Gerber et al. , 1989). It has
recently been reported that adenosine-induced 
hyperpolarisation was depressed by glibenclamide, a blocker 
of ATP-sensitive K+ channels, in rat CA1 neurones (Li and 
Henry, 1992).
There is also growing evidence that adenosine, in 
addition to potassium and calcium currents, may also affect 
chloride movement via the Aj receptor in hippocampal 
neurones (Mager et al., 1990,1995).
1.4. Phosphatidylinositol turnover
Stimulation of adenosine receptors primarily regulates 
the activity of adenyl cyclase, but adenosine also 
interferes with the hydrolysis of phosphoinositides (Pis). 
These compounds comprise one of the major transmembrane 
transducing systems in the mammalian brain. Unlike
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acetylcholine, noradrenaline, serotonin and histamine, 
adenosine does not seem to have any direct effects on PI 
hydrolysis (El-Etr et al., 1989). However, it is involved 
in the regulation of the PI response to some of the 
transmitters such as histamine and noradrenaline. In the 
striatum, adenosine receptors potentiate the response to 
the muscarinic agonist carbachol (El-Etr et al. , 1989).
Histamine Hj-receptor-stimulated PI breakdown has been shown 
to be inhibited by adenosine in mouse (Kendall and Hill, 
1988) and human cerebral cortex (Kendall and Firth, 1990) 
and in rat striatum (Petcoff and Cooper, 1987). In 
contrast, the histamine-stimulated PI turnover in guinea- 
pig cortex is increased by adenosine agonists 
(Hollingsworth et al., 1986).
Alexander and co-workers (Alexander et al. , 1989)
reported that the adenosine receptor mediating the 
modulation of histamine-stimulated PI hydrolysis is 
different to the receptor that stimulates cAMP formation. 
Inhibition of PI hydrolysis by adenosine seems to involve 
a direct inhibition of phospholipase C (Linden and 
Delahunty, 1989), the enzyme involved in the formation of 
the two second messengers of this transmembrane transducing 
system, inositol-1 ,4,5-trisphosphate and diacylglycerol.
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1.5. Potassium Channels
Potassium channels are involved in a number of central 
nervous system processes including neuronal depolarisation 
and neurotransmitter release. It was originally 
hypothesized that hyperpolarisation induced by opening the
potassium channels leads to suppression of neurotransmitter
2+release by preventing the opening of voltage-dependent Ca 
channels (Quast and Cook, 1989).
It has recently been reported that the adenosine 
potassium channel is ATP-sensitive type (Li and Henry, 
1992) . ATP-sensi tive potassium (KATp) channels are from a 
group of potassium channels that occur in muscle tissue, in 
pancreatic 3  cells and in transporting and neuronal tissue 
(Nichols and Lederer, 1991). The ATP-dependent potassium 
channel is modulated by intracellular concentrations of ATP 
such that normal physiological concentrations of ATP 
inhibit the channel. However, if ATP levels decline the 
channel opens (Noma, 1983). Several other endogenous 
modulators of cellular K^p channel activity have been 
identified including the ATP/ADP ratio, certain nucleotide 
diphosphates, pH, lactate and G-protein kinase (Edwards and 
Weston, 1990). Several pharmacological agents have also 
been discovered that specifically modulate the KATp channel.
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The potassium channel openers, which include nicorandil, 
levocromakalim, pinacidil and aprikalim activate the KATp 
channel (Edwards and Weston, 1990). The sulfonylurea agents 
glibenclamide and tolbutamide and the non-sulfonylurea 
compound sodium 5-hydroxydecanoate specifically block K^p 
channels (McCullough et al. , 1991). Indeed, in pancreatic 
cells, where channel function is relatively well
understood, depolarization induced by elevated ATP levels
2+subsequent to glucose metabolism opens voltage-gated Ca 
channels to release insulin.
1.6. Treatment perspectives of adenosine
The concentrations of adenosine in brain rise during 
hypoxia (Winn et al. , 1981), ischaemia (Berne et al. , 1974; 
Kleihues et al. , 1974) and seizures (Winn et al. , 1980).
For example, after ischemia, adenosine levels in the 
millimolar range have been measured (Berne et al., 1974). 
In this view, it seems that adenosine may play a 
neuroprotective role in cerebrovascular diseases.
It has been shown that glutamate-gated cation channels 
play a key role in triggering ischaemia (Coyle and 
Puttfarcken, 1993). Several experimental data have shown 
that activation of Aj adenosine receptors causes a marked
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reduction in amount of excitatory transmitter release (Yoon 
and Rothmann, 1991). Thus, it may have a beneficial 
neuroprotective role (Rudolphi et al., 1992; Phillis et
al., 1993). Adenosine can prevent seizures in vivo (Murray 
et al. , 1985, 1993; Dragunow et al. , 1985; Young and
Dragunow, 1994) and in humans models (During and Spencer, 
1992; Kostopoulos et al., 1989). Moreover, there are 
several reports that indicate adenosine antagonists can 
induce seizures (Skinner, 1990). Indeed, the convulsant 
action of theophylline and caffeine is used to facilitate 
electroconvulsive treatment in patients with psychiatric 
disorders (Hinkle et al., 1987).
Aj antagonism may result in the release of multiple 
neurotransmitters, including acetylcholine and serotonin. 
Therefore, Al antagonists might be useful in 
neurodegenerative cognitive disorders, such as Alzheimer’s 
disease, that are associated with degeneration of 
cholinergic and serotonergic neurones. Recent biochemical 
studies have shown changes in adenosine receptors in the 
brains of patients with Alzheimer’s disease (Jansen et al. , 
1990; Ikeda et al., 1993) .
In the heart, in addition to being a potent 
vasodilator, adenosine slows heart rate (negative 
chronotropic effect), slows atrioventricular (AV) nodal
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conduction (negative dromotropic effect), and antagonises 
the stimulatory effect (ie, inotropic and arrhythmogenic) 
of catecholamines (Belardinel1i et al. , 1989). These
effects of adenosine, which increase the supply of oxygen 
and decrease cardiac work, are cardioprotective 
(Belardinell and Shryock, 1992). Consistent with this 
cardioprotective action, adenosine and agents that increase 
the interstitial concentration of adenosine such as 
nucleoside uptake blockers and adenosine deaminase or 
adenosine kinase inhibitors, have been shown to reduce 
myocardial cell damage and dysfunction during hypoxia and 
ischemia (Ely and Berne, 1992). Thus, modulation of 
adenosine metabolism and/or adenosine receptor activation 
may prove beneficial in the treatment of cardiac 
arrhythmias and ischemic heart disease. Dipyridamole, an 
adenosine uptake inhibitor, is used clinically in ischemic 
heart disease.
It should be noted that there is still a technical 
problem in the use of adenosine or adenosine analogs in the 
brain since adenosine crosses the blood-brain barrier 
poorly.
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A possible strategy to solve this problem is to use an 
agonist which is able to pass the blood-brain barrier and 
an antagonist which is unable to pass the blood-barrier to 
minimise cardiovascular adverse effects of adenosine.
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1.7. GABA as an inhibitory neurotransmitter in the brain
GABA is well known as the major inhibitory 
neurotransmitter in the mammalian brain. There is evidence 
to suggest that the nervous system is held in a state of 
perpetual restraint, by circuits which tonically inhibit 
pacemaker neurons and feedforward and/or feedback cell 
discharges, surround and dampen the output of spontaneously 
discharging neurones, and influence pre-synaptic inhibition 
and facilitation. The CNS operates by relaxing these 
restraints (i.e. disinhibition) via excitatory inputs. The 
majority of this inhibitory wiring is comprised of neurones 
which release GABA as their neurotransmitter.
GABA was first identified in the brain in 1950 
(Awapara et al. , 1950; Robert and Frankel, 1950) and
shortly afterward its involvement in the mediation of 
seizure activity became apparent. Hayashi observed that 
direct application of GABA onto the motor cortex of the dog 
attenuated local epileptic discharge (Hayashi and Nagi, 
1956; Hayashi, 1959) and Killam and Bain (1957) reported 
inhibition of GABA synthesis to be the principle mechanism 
of action of the convulsant hydrazides. Understanding of 
the synthesis (Weinstein et al, 1963) release (Jasper et 
al. , 1965), postsynaptic effects (Krnjevic and Schwartz,
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1987), specific antagonism (Galindo, 1969), and
inactivation (Robert and Kuriyama, 1968) of GABA followed
and precipitated its proposal as an inhibitory
neurotransmitter in the mammalian brain.
GABA is formed, de novo, entirely from L-glutamic acid. 
This reaction is catalysed by the enzyme GAD (glutamate 
decarboxylase) in the presence of pyridoxal phosphate as a 
cofactor (Meldrum, 1957). GAD is exclusively localised to 
GABAergic neurones in the vertebrate CNS and can be
employed as a definitive marker for these cells (Snead,
1983).
Following synaptic release, GABA exerts its actions via 
specific cell membrane receptors. At present three specific 
receptor sites for GABA have been identified in the 
mammalian brain and have been designated GABAA, GABAg and 
GABAC.
1.7.1. GABAA receptor
The GABAa receptor has been the subject of many studies 
(Olsen, 1982; Levitan et al., 1988; Olsen and Tobin, 1990) 
and is now well characterised. Extensive research has shown 
the GABAa receptor to be a macromolecular protein, composed
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of five variable subunits, forming a chloride ion-selective 
channel and possessing additional binding sites for 
benzodiazepines (Ehlert, 1986), barbiturates (Willow and 
Johnston, 1983), picrotoxin (Olsen, 1981), penicillin 
(Twyman et al, 1992), and neurosteroids (Majewska et al,
1986) . Binding of GABA to this receptor subtype leads to 
opening of the channel, chloride ion entry into the cell, 
hyperpolarisation, and inhibition of action potential 
generation (Enna and Gallagher, 1983). cDNA cloning has 
revealed the existence of a number of distinct subunit 
isoforms. Based on sequence similarity, five different GABAA 
receptor subunit families have been identified and have 
been named a, 3, 7, 8, and e subunits. Most of the families 
have multiple subtypes (a^, Pj_A, Yj_ 3 8  and e^) > and the 
sequences within each subunit family show homology, with 
about 70-80% amino acid sequence identity. Although GABA^ 
receptors per se are distributed widely, determination of 
the regional distribution of receptor subunits, by in situ 
hybridization, has confirmed that many of the subunits are 
highly localised within the brain (Macdonald, 1993) and may 
be responsible for the heterogeneity of GABAA receptors 
previously reported in binding studies (Olsen et al. , 1984; 
McCabe et al., 1988).
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1.7.2. GABAg receptor
It was reported that (-)baclofen decreases 
neurotransmitter releases in the CNS (Bowery et al. , 1980). 
In 1981, it was established that this effect of (-)baclofen 
is exerted by activation of a bicuculline-insensitive and 
non-GABAA receptor (Hill and Bowery, 1981), and this 
receptor is termed the GABAg receptor. Although GABA and 
baclofen have been used as GABAg receptor agonists, studies 
on physiological and pharmacological roles of the GABAg 
receptor in the CNS have been delayed, mainly by the lack 
of selective and potent antagonists for this receptor. 
Recently, however, selective and potent agonists and 
antagonists for the GABAg receptor have been introduced. For 
example, 3-aminopropylphosphonoic acid (APPA) has been 
developed as a potent agonist at peripheral and central 
presynaptic GABAg receptors (Ong et al. , 1990). On the other 
hand, phaclofen, 2 -hydroxysaclofen and more recently 
CGP35348 have been introduced as selective antagonists for 
the GABAg receptor (Kerr et al., 1987, 1988; Curtis et al., 
1988; Olpe et al., 1990).
In electrophysiological studies, it was demonstrated
that activation of the GABAg receptor results in modulation
2+of ion channels. Namely, a voltage-dependent Ca channel
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was inhibited by activation of the GABAg receptor (Holz et 
al, 1986). In addition, activation of the GABAg receptor
induced an increase in K+ conductance, which resulted in the 
occurrence of a slow IPSP (Newberry and Nicoll, 1984; Dutar 
and Nicoll, 1988). Modulation of these ion channels by the 
GABAg receptor was also known to be mediated by GTP-binding 
protein. Therefore, it seems likely that suppression of
transmitter release by activation of the presynaptic GABAg
2+receptor is caused by a decrease in Ca conductance or an 
increase in K+ conductance.
1.7.3. GABAg receptor
Recently, GABA-gated Cl channels with unusual 
pharmacology have been detected in the vertebrate retina, 
which do not fit into the conventional scheme of GABAA and 
GABAg receptors (Polezani et al., 1991; Feigenspan et al., 
1993a,b; Quian and Dowling, 1993). It is very likely that 
these receptors, termed GABAg (Shimada et al. , 1992), are
composed of the or Qj subunits (Cutting et al.,
1991,1992). The novel bicuculline and baclofen-insensitive 
GABAg receptors are present on rat retinal bipolar cells 
(Feigenspan et al. , 1993a,b) and on horizontal cells of
white perch (Qian and Dowling, 1993). GABAg receptors may 
exert an important inhibitory role in the retinal 
circuitry.
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1.7.4. Metabolism and uptake of GABA
Following receptor activation, GABA is removed from its 
site of action, in the synaptic cleft, by a high affinity 
uptake mechanism (Logan and Synder, 1971). This process, 
together with direct diffusion of GABA into postsynaptic 
nerve cell bodies (Hyden et al., 1986), appears to be one 
of the most significant mechanisms of GABA inactivation and 
can be observed in both neurones and glial cells (Iverson 
and Kelly, 1975). Upon cellular uptake, GABA is 
successively metabolised by the action of two mitochondrial 
enzymes. GABA-T (GABA transaminase) catalyses the 
conversion of GABA to succinic semialdehyde (SSAD) in the 
presence of a a-Ketoglutarate as cofactor and SSAD 
completes the metabolism to succinate in the presence of 
nicotinyl adenine dinucleotide (NAD; Meldrum, 1975).
1.7.5. Peripheral actions of GABA in vertebrates
The first observation of a peripheral action of GABA in 
a mammal was made by De Groat (1970) working on feline 
autonomic ganglia. By now, the idea of an exclusively 
central role of GABA has been superseded by many findings 
which show that enzymes for the synthesis and uptake of 
GABA, as well as GABA receptors (both GABAA and GABAg), are
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widely spread in the autonomic nervous system and in a 
number of neuroendocrine, endocrine and exocrine cells 
(Erdo and Wolff, 1990).
1.7.6. GABA as link between neuronal and hormonal control 
systems
A vast body of evidence suggests that GABA acts as an 
important bilateral link between the nervous system and the 
endocrine system. One aspect of this interaction is that 
various neuroendocrine and endocrine cells receive a 
GABAergic innervation and show responses mediated by GABAA 
and GABAg receptors (Randle and Renaud, 1987; Peters et al. , 
1988). On the other hand, certain steroid hormones and 
hormone metabolites are capable of potentiating the 
inhibitory actions of GABA through a modulatory effect on 
the GABAa receptor (Majewska et al, 1986; Twyman and
Macdonald, 1992).
1.7.7. Neuroactive steroid action at the GABAA receptor
The GABAA receptor is a complex membrane-bound protein 
which is coupled to a Cl" channel. Upon binding to the 
receptor, GABA facilitates the opening of the Cl’ channel 
resulting in hyperpolarisation of the neuron.
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Therapeutically useful anticonvulsant, anxiolytics, and 
sedative-hypnotics such as the benzodiazepines and 
barbiturates are known to act through their binding sites 
on the GABAa receptor complex (Stephenson, 1988). These 
agents are positive GABAA allosteric modulators that 
increase the binding of GABA to the GABAA receptor. 
Conversely, negative GABAA receptor modulators such as 3” 
carbolines that decrease the binding of GABA to the GABAA 
receptor, are anxiogenic or convulsants.
The discovery of neuroactive steroids and their 
distinct binding site on the GABAA receptor complex raises 
the possibility that this class of steroids may have 
therapeutic potential like other GABAA receptor ligands. 
Neuroactive steroids are found endogenously. The most 
potent naturally occurring neuroactive steroids are 3a- 
hydroxy-5a-pregnane-20-one (3a,5a-P) and 3a,21-hydroxy-5a- 
pregnane-20-one (5a-THDOC) which are metabolites of 
progesterone and deoxycorticosterone, respectively. These 
steroids are positive allosteric modulators of the GABAA 
receptor.
A second group of neuroactive steroids represented by 
pregnenolone and dehydroepiandrosterone and their sulfate 
metabolites have been shown to be negative modulators of
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the GABAa receptor (Majewska and Schwartz, 1987). 
Collectively biochemical, pharmacological and physiological 
studies support the existence of a novel binding site for 
neuroactive steroids on the membrane-bound GABAA receptor 
complexes in the mammalian brain.
1.8. Chloride channels
Chloride is the most important physiological anion. 
Several pathways for chloride exchange between the 
extracellular and intracellular milieu exist, including Cl" 
HCOj" exchange, NaHCOj-HCl exchange, Na-K-2C1 cotransport, 
K-Cl and chloride channels (Palfrey and Rao, 1983; Warnock 
and Eveloff, 1989). Chloride channels in intracellular 
compartments are often found in conjunction with active 
cation transport systems where chloride appears as a 
counter ion to the transported cation. Plasma membrane 
chloride channels serve a variety of physiological roles. 
For excitable cells that change their membrane potential 
over wide ranges, activation of chloride channels 
stabilizes the membrane potential. This has an inhibitory 
effect on action potential generation because chloride 
equilibrium potential is close to resting membrane 
potential. The function of GABA and glycine receptors is 
based on this effect. In addition to this, in many
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epithelia, chloride channels are essential for transport of 
salt (and water) across the cell layer (Hoffmann and 
Ussing, 1992). Ligand-gated chloride channels which are the 
most important class of chloride channels, are activated by 
the binding of an external messenger molecule. Typical 
representatives of this class are postsynaptic GABA and 
glycine-activated chloride channels. Structurally, these 
belong to a superfamily of direct transmitter-activated ion 
channels which also includes cation channels (Barnard et 
al, 1987).
Adenosine 3’,5’-cyclic monophosphate (cAMP)-dependent 
chloride channels are activated by a rise in intracellular 
cAMP. The molecular mechanism is often phosphorylation by 
cAMP -dependent protein kinase A (PKA), but it cannot be 
excluded that other chloride channels may be directly 
activated by binding of cyclic nucleotides (Dhallan et al. ,
1990). An important example for activation by cAMP- 
dependent phosphorylation is the cystic fibrosis 
transmembrane conductance regulator (CFTR) chloride channel 
(Riordan et al. , 1989), which also requires the
intracellular binding and probably also hydrolysis of 
nucleotides for activity (Baukrowitz et al. , 1994). The
CFTR is involved in transport across many epithelia 
(Riordan et al., 1989).
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Another important class of chloride channels is 
activated by elevated intracellular calcium (Marty et al.,
1984). In many cases, it is not known whether calcium acts 
directly by binding to the channel protein, or via an 
interposed mechanism such as phosphorylation. To date, 
little biochemical information is available for calcium- 
dependent chloride channels. It should be noted that 
chloride channels largely have been ignored by many 
physiologists, but recently, interest in anion channels has 
increased significantly after the invention of the patch- 
clamp technique.
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1.9. Glutamate as an excitatory neurotransmitter in the 
brain
L-glutamate is an endogenous excitatory amino acid 
neurotransmitter substance that contributes excitatory 
input into the majority of synapses in the central nervous 
system (Founum, 1984). During the intervening years a 
wealth of information pertaining to excitatory amino acids, 
and glutamate in particular, has been generated. Much is 
now known about the synthesis (Peng et al., 1991), release 
(Nicholls and Attwell, 1990), receptor-mediated effects 
(Monaghan et al. , 1989) and inactivation (Schousboe et al.,
1988) of neurotransmitter glutamate. Glutamate can be 
synthesised, de novo, by transamination of a-ketoglutarate 
catalysed by aspartate aminotransferase, by direct 
amination of a-ketoglutarate catalysed by glutamic acid 
dehydrogenase, and by the deamination of glutamine 
catalysed by glutaminase. All of these mechanisms have been 
implicated in the synthesis of neurotransmitter glutamate 
(Peng et al., 1991).
Astrocytes are believed to play the principal role here 
by synthesising and supplying the necessary precursors 
(Sonnewald et al., 1991). Synaptic release of glutamate is 
a calcium-dependent phenomenon, can be induced by
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potassium, veratridine, or 4-AP depolarisation, and can be 
blocked by magnesium in a voltage sensitive manner (Horton, 
1989; Nicholls and Attwell, 1990).
1.9.1. Glutamate receptor
Glutamate receptors are found throughout the mammalian 
brain, where they constitute the major excitatory 
transmitter system (Col1ingridge and Lester, 1989). The 
well-known glutamate receptors are ligand-gated ion 
channels (Monaghan et al., 1989) which are called
ionotropic glutamate receptors and are permeable to 
cations. They have been categorised into three broad 
subtypes based upon pharmacological and 
electrophysiological features: a-amino-3-hydroxy-5-methyl-
4-isoxazole propionate (AMPA) receptors, Kainate (KA) 
receptors, and N-methyl-D-aspartate (NMDA) receptors 
(Nakanishi, 1992). Recently, however, a family of G 
protein-coupled glutamate receptors, which are also called 
metabotropic glutamate (Miller, 1991) or trans-1- 
aminocyclopentane-1,3-dicarboxylate (tACPD) receptors, was 
identified (Sugiyama et al. , 1987; Collingridge and Lester,
1989). There are at least six subtypes of metabotropic 
glutamate receptor which are coupled to activation of 
phosphoinositide hydrolysis, and thus the mobilization of
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intracellular calcium (Nakanishi, 1992; Tanabe et al. ,
1992). Most recently a 2-amino-4-phosphonobutyric acid 
(AP4) receptor has been reported as a new subtype of 
ionotropic glutamate receptor (Nakanishi, 1992). The AP4 
receptor is less well characterised and is thought to be a 
presynaptic autoreceptor, providing a negative feedback 
mechanism to reduce further neuronal glutamate release 
(Scatton, 1993).
Inactivation of glutamate following its synaptic 
release occurs via a high affinity, sodium and energy- 
dependent uptake system present in both nerve endings and 
glia (Drejer et al., 1982). Recent evidence suggests that 
glial uptake is more important than neuronal uptake in the 
rapid removal of glutamate from the synaptic cleft
(Schousboe et al., 1988). Autoradiographic measurement of 
glutamate uptake, and lesion studies of anatomically
defined pathways, have facilitated identification of
numerous glutamatergic pathways in the mammalian brain 
(Fagg and Foster, 1983). The majority of glutamate 
releasing pathways appear to be descending, originating in 
the neo and allo-cortex and innervating many sub-cortical 
regions and the spinal cord. Many cortico-cortical
projections also employ glutamate as a neurotransmitter.
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distinct allosteric sites for zinc ions, polyamines, 
phencyclidine (PCP and ketamine) and for glycine, which are 
closely associated with the ion channel of this complex 
(Lodge and Johnson, 1990).
1.9.3. Role of glutamate receptors in learning, memory and 
brain disorders
A generally accepted hypothesis in neurobiology has 
been that at the cellular level, memories are stored, at 
least in part, as long-term changes in the strength of 
synaptic transmission as a result of alterations in the 
efficacy of chemical synapses (Hebb, 1949). The glutamate 
receptor has become the focus of much work because of 
several experimental findings that indicate a central role 
for glutamate receptors in learning and memory (Bliss and 
Col1ingridge, 1993). The NMDA receptor has attracted much
attention because its properties make it an ideal candidate 
for a receptor involved directly in the learning process. 
The NMDA receptor is the only ligand-gated ion channel 
whose probability of opening depends strongly upon the 
voltage across the membrane, under physiological 
conditions. This property permits this receptor to operate 
as a Hebbian molecule (Hebb, 1949).
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A vast body of evidence suggests that glutamate 
receptors play a role in a number of cerebrovascular 
diseases (Appel, 1993), indeed, many neurological accidents 
involving strokes in which there is a loss of oxygen and 
glucose, or epilepsy, result in brain damage because of 
over-stimulation by glutamate. It has also been proposed 
that degenerative diseases such as Alzheimer’s, 
Huntington’s and amyotrophic lateral sclerosis (ALS) may 
involve neuronal cell death caused by over-activation of 
the glutamate receptor system (Coyle and Puttfarcken,
1993).
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1.10. Hippocampus and memory system
Learning is a neural process which enables both human 
and animals to adapt to their environments by using 
experience to adjust their behaviour. The mechanisms of 
learning and memory have traditionally been interesting 
topics of study. It has been known for years that the 
hippocampal system plays a crucial role in learning and 
memory. The hippocampus is ideal for studies of memory and 
learning for two reasons. First, the hippocampus can serve 
as a model for cortical processing in general because of 
its regular and relatively simple cytoarchitecture. Second, 
the size and central location of the hippocampus indicates 
that is plays ajprominent role in total brain function. 
Only recently has it become clear that only certain 
properties of memory processing depend on hippocampal 
system function and that these can be distinguished from 
other aspects of memory that do not. The earliest reports 
of amnesia emphasized the time limited role of the 
hippocampal region in memory, focusing on its critical 
function in consolidation processes that bridge between 
immediate memory and the long-term store (Scoville and 
Milner 1957). Amnesic patients and animals with hippocampal 
lesions show some disorders in temporary memory store 
(Rawlins 1985).
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A generally accepted hypothesis in neurobiology has
been that long-lasting activity-dependent changes in the 
efficacy of synaptic transmission in the mammalian brain 
are considered to be of fundamental importance for the
development of neural circuitry and for the storage of 
information (Hebb, 1949; Nicol et al., 1988). The most
compelling and reliable model for such changes has been 
long-term potentiation (LTP) and long-term depression (LTD) 
in the hippocampus.
1.10.1. Long-term potentiation
The storage of information in the hippocampus is 
believed to involve an increase in synaptic efficiency. 
This view was confirmed by the report of Bliss and Lomo 
(1972,1973) that brief, high-frequency activation of some 
hippocampal pathways could evoke an increase in the 
synaptic efficiency. This phenomenon is regarded as LTP 
(Bliss and'Lomo , 1972, 1973). LTP has three propertiesi
which distinguish it from other forms of post-excitatory 
facilitation. Firstly, LTP has an extremely long duration 
and can last for days. However, it is necessary to
emphasize that LTP is not permanent. Secondly, it enables
long-lasting increments of synaptic efficiency to be 
produced by short, high-frequency stimulus trains and
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finally, LTP seems to need a number of co-active convergent 
synapses to be activated (Lee, 1983). There is increasing
evidence that this form of synaptic plasticity underlies
2+some forms of memory. The rise in intracellular Ca level 
that can occur by activation of glutamate receptors of the 
N-methyl-D-aspartate (NMDA) type (Col1ingridge and Lester, 
1989) is crucial for induction of LTP. However, it should 
be stressed that there exist forms of LTP that are not 
dependent upon NMDA receptor activation (Johnston et al. , 
1992). It has been reported that LTP induction at mossy 
fibres synapses in area CA3 of hippocampus is independent
of NMDA receptors (Johnston et al., 1992), whereas in the
CA1 region, LTP is a result of Ca^+ influx through the NMDA 
receptor-associated ion channel (Col1ingridge et al. , 1983; 
Kauer et al., 1988).
1.10.2. Long-term depression
The term, long-term depression (LTD) may apply to any 
form of long lasting depression in synaptic transmission. 
LTD has been described in several brain regions, including 
hippocampal region CA1 (Levy and Steward, 1979), the 
dentate gyrus, visual cortex (Artola and Singer, 1990),
frontal cortex (Hirsch and Crepel, 1992) and cerebellum
(I to et al. , 1982). Although LTD of evoked responses has
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been reported in the hippocampal formation following a 
variety of stimulation procedures, most paradigms can be 
categorised into homosynaptic, heterosynaptic and
associative LTD according to the level of presynaptic 
activity in the pathway undergoing LTD induction, as well 
as that in converging afferents (Braham and Srebro, 1987: 
Artola and Singer, 1993; Lovinger et al. , 1993; Linden,
1994). The heterosynaptic LTD can be produced by 
presynaptic activation of different inputs on to the same 
post synaptic cell but homosynapt ic LTD can be induced by 
presynaptic activation of the same input on to the relevant 
neurone.
Associative LTD is a persistent decrease in synaptic 
strength that is produced while presynaptic activity occurs 
out of phase with strong postsynaptic activity, with the 
postsynaptic activity being driven by converging afferents. 
Owing to hyperpolarisation of the postsynaptic cell in the 
periods between strong postsynaptic activity, this results 
in presynaptic activity occurring in the absence of 
postsynaptic activity (Linden, 1994) .
Several factors have been reported to trigger LTD, 
including the induction of LTP, depolarization of 
postsynaptic sites, activation of NMDA and non-NMDA 
receptors, activation of metabotropic glutamate receptors
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2+and moderate postsynaptic Ca influx (Kano and Kato, 1987: 
Aroniadou and Teyler, 1991: Yang et al., 1994). It has been
reported that both homosynaptic and associative LTD are
2+abolished by antagonists of NMDA receptors and Ca
2+chelators. In associative LTD, voltage-dependent Ca 
channels have also been shown to be important for induction 
(Christie et al., 1994: Debanne and Thompson, 1994).
Homosynaptic LTD has been found in a number of brain 
structures using one of two induction protocols: prolonged 
afferent stimulation at low frequency (1-5 Hz for 5-15 
minutes) or stimulation at high frequency (50-100 Hz for 1- 
5 seconds)(Linden et al., 1994). Low frequency stimulation 
has been shown to induce homosynaptic LTD in the 
hippocampus but high frequency stimulation has been 
effective at striatal synapses (Braham and Serbro, 1987; 
Lovinger et al. , 1992) . On the other hand, induction of
heterosynaptic LTD requires a strong postsynaptic 
depolarization caused by synaptic activation. It should be 
noted that heterosynaptic depression in area CA1 has proved 
difficult to investigate, as several groups have failed to 
induce this type of LTD at all (Linden et al., 1994).
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1.10.3. Calcium and neuronal plasticity
Intracellular calcium concentration has been proposed to
play a pivotal role in neuronal plasticity (Malenka et al.,
2+1989). Several families of Ca -activated enzyme are known
to be colocalized in synaptic structures. One type of
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protein kinase, Ca /calmodulin-dependent (CaM) kinase,
becomes activated in the presence of calmodulin and
2+elevated intracellular Ca . Recent progress in elucidating 
the mechanisms underlying synaptic plasticity indicates
that both forms of plasticity require NMDA receptor-gated
2+ 2+Ca influx, whereas voltage-dependent Ca influx can also
contribute to the generation of LTD.
It has been reported that moderate elevation of
2+intracellular Ca triggers LTD, whereas higher 
concentrations are required to initiate LTP (Christie et 
al. , 1994; Debanne and Thompson, 1994; Hirano et al. ,
1994).It appears as though the strength of a given synapse 
can be set between some minimum and maximum level by 
induction of LTD or LTP (Lisman, 1989). These two extremes 
seem to be determined by the level of phosphorylation of
some as yet undefined substrate. Induction of LTD decreases
2+their level of phosphorylation by triggering Ca dependent 
protein phosphatase, while induction of LTP increases their
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2+phosphorylation by triggering Ca -dependent protein
kinases. These kinases apparently require larger increases
2+in intracellular Ca for activation than do the 
phosphatases.
1.11. Anatomy of hippocampus
In the brains of mammals the hippocampus is a 
bilaterally represented structure that appears as a ridge 
extending into the lateral ventricle. The outer surface of 
the hippocampus is composed of myelinated fibers arising, 
in part, from cells of the hippocampus, most of which leave 
the region through a large efferent pathway, the fornix. 
The outer coating of the hippocampus is white due to the 
myelin coating of the axons of which it is made . The outer 
covering is called the alveus, and fibres in it give rise 
to the fimbria that, in turn , is continuous with the 
fornix (Isaacson, 1987). The hippocampal formation can be 
divided into the Ammon’s horn, the dentate gyrus, and 
subiculum. Based on Golgi preparations, the anatomist 
Lorente de No divided Ammon’s horn into four subfields: CA 
(Cornu Ammonis) 1 to CA4. More recent evidence strongly 
supports the view that the CA4 zone belongs to the dentate 
gyrus (Witter, 1989). From the outer layer to more medial, 
Ammon’s horn contains alveus, and strata oriens,
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pyramidale, radiatum, lacunosum and the molecular layer. 
The dentate gyrus consists of closely packed cells which 
are called granule cells. These cells have dendritic 
brushes that extend only in one direction- toward the 
outer, molecular layer of the gyrus (Isaacson, 1987). The 
distal part of CA1 borders the subiculum which is distally 
replaced by the pre- and para subiculum, and the adjacent 
entorhinal cortex ventrally and retrosplenial cortex 
dorsally (Witter, 1989; Isaacson, 1987).
1.11.1. Intrinsic connectivity of hippocampus
Neuronal input reaches the hippocampus from entorhinal 
regions, which send a digest or summary of what is 
occurring in the neocortex and consequently, the 
environment, to the hippocampal formation. The entorhinal 
cortex by the perforant pathway has a massive projection 
predominantly in the dentate gyrus. Projections to Ammon’s 
horn also have been described (Witter, 1989). The granule 
cells of the dentate gyrus project through their mossy 
fibres to CA3. Pyramidal cells in CA3 give rise to 
collateralized axons of which the so-called Schaffer- 
collaterals provide the major input to CA1 . From cells in 
the CA3 area axons leave the hippocampus via the fimbria 
and fornix, largely terminating in the lateral septal area.
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In general, the Schaffer collaterals synapse in the stratum 
radiatum and stratum oriens with the dendrites of CA1 
pyramidal cells. Finally, neuronal output from the CA1 
cells exit into the alveus and subsequently into the 
fornix, also projecting in large part to the septal area 
and the subicular region (Isaacson, 1987, figure of 
hippocampus).
1.11.2. Hippocampal Slices
Since the demonstration that slices of mammalian CNS 
tissue were physiologically viable in vitro (Yamamoto and 
Mcllwan, 1966), the hippocampal slice preparation (Skrede 
and Westgaard, 1971) has been extensively used in 
neurochemical and electrophysiological experiments. Several 
aspects of the slice preparation facilitate this type of 
analysis (Dunwiddie et al., 1983). The lamellar structure 
of hippocampus (Andersen et al. , 1971), with its rather
simple three-layered cortex, well-defined input and output 
pathways makes it a natural choice for a slice preparation 
(Schwartzkroin, 1987).
Compared with in vivo experiments, in vitro slice 
models, like hippocampal slices, have advantages:
-No interaction of substances with anaesthetics.
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-From a single animal a large number of measurements can be 
performed simultaneously in different systems (measuring 
chambers) (saving of animals).
-Direct visualization of the measured or stimulated brain 
areas.
-Possibility of determining true dose-response curves with 
substance application in the bath.
-Possibility of substance application both in the bath and 
also locally with micropipette release.
-No indirect (peripheral) substance effects, only CNS 
substance action.
-Very stable intracellular measurement (no movement).
-Technical simplicity and multiplicity.
-Easy changing of extracellular fluid.
Brain slices, like all preparations, have
disadvantages and limitations as follows:
-Blood-brain barrier no longer present (passive diffusion).
-The composition of the perfusion solution does not 
correspond to that of the natural extracellular medium.
-Disconnection of inhibitory and excitatory input and 
output pathways.
-Trauma and anoxic period of dissection.
-Limitation of tissue life-acute nature of the preparation 
(Schwartzkroin, 1981,1987; Clark and Wilson, 1992).
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METHODS AND MATERIALS
2. Methods and materials
2.1. Preparation of slices
Male Wistar rats (170-200g) were anaesthetised with 
urethane (1.3g/Kg I.P.) and decapitated using a Guillotine. 
The scalps were removed and brains were rapidly taken out
and put in ice-cold artificial cerebrospinal fluid (ACSF).
The cerebellum was removed and the two cerebral hemispheres 
were separated with a surgical blade. The hippocampi were 
carefully pulled out with spatulas and put on the filter 
paper and cut transversely into 450 piM thick slice using a 
Mcllwain tissue chopper. The slices were then transferred 
onto another filter paper in a petri dish containing ice- 
cold oxygenated ACSF and separated with glass seekers. The 
petri dish, with slices, was put into the incubation 
chamber containing an ACSF-saturated atmosphere of 95% 02 
and 5% C02 at room temperature for at least one hour before 
using. The fluid in the petri dish was adjusted to cover
the slices (fiure 2.1.).
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Figure 2.1. Anatomy of the hippocampal formation and the 
placement of the electrodes. (A). The hippocampal formation 
is enlarged to show the main neuronal elements of 
structure. (B). Lateral view of the rat brain with parietal 
and temporal neocortex to expose the hippocampal formation, 
after orthodromic stimulation of Schaffer collateral fibres 
in stratum radiatum near the border of CA2-CA3, recordings 
were made in the CA1 pyramidal cell layei or the stratum 
radiatum for population spikes (P.S.) or field EPSPs 
(fEPSP) respectively. Stimulation of the alveus was used to 
induce antidromic invasion of CA1 cells as shown in (A). 
Abbreviation for figure: alv.= alveus; D.G= dentate gyrus; 
ento.= entorhinal area; fim.= fimbria; mf.= mossy fibres; 
pp.= perforant path; sch.= Schaffer-collaterals; mm= 
millimeter. (Revised from Andersen et al., 1971).
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2.2. Bathing medium
The formula of the bathing medium, artificial 
cerebrospinal fluid (ACSF), was as follows (mM): NaCl 115; 
KH2P04 2.2; KC1 2.0; MgCl2 1.2; CaCl2 2.5; NaHCOj 25 and 
glucose 10.
In some antidromic experiments, calcium was omitted and 
MgCl2 was raised from 1.2 to 4 mM (calcium-free high 
magnesium).
2.3. Bath superfusion and application of drugs
Individual slices were then transferred using a fine 
brush to a 1ml capacity recording chamber and superfused 
with ACSF at 30°C ± 0.5, gassed with 02/C02 mixture to 
yield a pH of 7.4. The slices were completely submerged in 
the medium which was perfused continuously from a gravity 
feed at a rate of 4 ml/min.
In some experiments adenosine was applied locally to 
the somatic or dendritic region of pyramidal cells using 
pressure ejection from glass micropipettes (8-10 mM tip 
diameter), containing agent solution. In this set of 
experiments an attempt was made to maintain the fluid layer 
covering the slice as thin as possible.
51
2.4. Recording electrodes
The electrodes for recording were made from 
borosilicate glass tubing containing a glass capillary fibre 
for easy filling. The tubing, with characteristics of 1 mm 
internal diameter and 2 mm external (GC 200 F) , was 
purchased from Clark Electromedical Instruments, U.K.. With 
a Kopf vertical electrode puller the electrodes were pulled 
and separated to yield two sharp tip electrodes. Under 
microscopic vision, the tips of the electrodes were broken 
with a glass probe to provide a tip diameter 2-4 pm. The 
electrodes were filled with 2 M sodium chloride via a 
syringe bearing a 0.2 pm syringe filter.
2.5. Recording and stimulation
After orthodromic stimulation of Schaffer collateral 
fibres in stratum radiatum near the border of CA2-CA3, 
recordings were made in the CA1 pyramidal cell layer or the 
stratum radiatum for population spikes or field EPSPs 
(fEPSPs) respectively. Stimulation of the alveus was used to 
induce antidromic invasion of CA1 cells by a bipolar 
electrode (figure 2.2.). Pulses of 0.1 ms duration and 100- 
500 pA amplitude were delivered every 100 seconds (0.01 Hz).
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The slices were maintained in the perfusion chamber for 
15 minutes before proceeding with any further 
experimentation. In long-term depression experiments, only 
slices exhibiting orthodromic potentials of between 9 and 12 
mv were used for drug applications. Other Slices were 
discarded.
For orthodromic fEPSPs the duration of the stimulus was 
decreased to 20-50 |is • Recordings were made with 2-4 pirn 
diameter glass microelectrodes containing 2 M NaCl. The 
recorded signals were amplified by a Neurolog amplifier and 
displayed on a Gould storage oscilloscope and then plotted 
on a thermosensitive chart recorder.
The orthodromic population spikes (P.S.), fEPSPs and 
also secondary spikes (S.S.) after antidromic stimulation 
were reduced to 75% to avoid supramaximal stimulation.
53
Orthodromic Stimulation
2 mv
1 mv1
10 ms
2 ms
Population Spikes fEPSPs
Antidromic Stimulation
Convulsant Agents or Media 2 mv
5
10 ms
Figure 2.2. Demonstration and measurement of orthodromic 
and antidromic potentials evoked in the CA1 region. 
Antidromic potentials are demonstrated in (A) normal ACSF 
and in (B) the presence of convulsant agents or media. 
Explanations of each part of the evoked potentials are as 
follows:
1) Stimulus artifact;
2) Presynaptic fibres volley potential that reflects the 
compound action potential travelling in the stratum 
radiatum towards CA1;
3) The population excitatory postsynaptic potential or 
reflects the depolarization of dendrites by the 
synaptically released transmitter;
4) The population spike is a negative going spike-like 
potential by the pyramidal neurones once the EPSP has 
depolarized the cells to threshold
5) The first antidromic spikes which reflect the compound 
action potential from axon to soma and initial 
depolarisation of the soma;
6) Secondary spikes that reflect firing of cell bodies;
7) Amplitude of population spikes, fEPSP or secondary 
spikes.
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2.6. Extracellular techniques
With extracellular measurements on individual neurones 
or neuron group it is possible to measure the spontaneous 
discharge rate of these cells. Optimum working conditions 
without external interference (e.g. mains and mains-borne 
signals) is achieved using a Faraday cage. If the 
excitatory fibres in the hippocampus are stimulated 
electrically and the evoked potentials measured in the 
region of the dendritic ending, the initial component of 
the response is a pre-synaptic fibres spike which is 
actually a summated action potential derived from axons and 
nerve endings. Directly following the fibre spike is the 
field EPSP (excitatory post-synaptic potential) response 
which is considered to mirror the population spike response 
measured in the cell body layer and is generated by the 
synchronous activation of a large neurone group.
If the axons of the neurons under investigation are 
stimulated electrically it is possible to measure the so- 
called antidromic population spike. It differs from the 
orthodromic population spike in that this response cannot 
be influenced by substances which have an effect on 
synaptic transmission. There are al^o many cases where the 
antidromic population spike is not modified by substances 
affecting the excitability of the neurones.
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2.7. Analysis of drug effects
The size of the population spike following orthodromic 
stimulation and the size of the first and secondary spikes 
following antidromic stimulation were measured as the peak 
to peak amplitude. The size of fEPSPs was measured between 
the negative going peak and the base line of stimulation 
(figure 2.2.).
Results were considered as percentage of change of the 
potential size by drug compared with control size. The size 
of evoked potential in the absence of any agents is 
considered as zero percent change in potential size.
2.8. Statistical analysis
Results are presented as mean % ± s.e.m (standard 
error of the mean) for n experiments, and the statistical 
significance of any difference assessed by a paired 
Student’s t-test. For multiple comparisons an analysis of 
variance (one way), ANOVA, with post test of Tukey-Kramer 
were used. Differences were considered significant with 
P<0.05 or as otherwise mentioned.
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2.8. Chemical agents
Constituents of ACSF were of Analar grade and 
purchased from BDH Chemicals Ltd. UK. Chemical agents 
generally were purchased from Sigma Chemical Co, UK, except 
for 8 - c y c 1o p e n t y 1-1 ,3-d i m e t h y 1x a n t h i n e  (8- 
cyclopentyltheophyl1ine; CPT), bicuculline methobromide, 
L (+)-2-amino-3-phosphonopropionic acid [L(+)-AP3], (±)-2-
amino-5-phosphonopentanoic acid (2-AP5), (1S,3R) ACPD and
quisqualic acid which were purchased from RBI. Veratrine 
was provided from B.D.H.
8-cyclopentylthyeophyl1ine (CPT) was dissolved in 
sodium hydroxide. The buffering capacity of the ACSF 
ensured that the final pH of the perfusing medium was 
restored to pH 7.4.
Veratrine, calcium ionophore A23187, alphaxalone and 
5a-pregnan-3a-ol-20-one were dissolved in ethanol. The 
concentration of ethanol in all experiments was less than 
0.01 %v/v and ethanol at this dilution did not show any 
effect by itself. In other cases the vehicle was the 
superfusing medium such as ACSF or ACSF without calcium.
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In teraction between adenosine and GABAa 
receptors on hippocampal neurones
3.1. INTRODUCTION
Adenosine is known to act as a general inhibitory 
modulator of synaptic transmission and neuronal activity in 
the peripheral and central nervous systems (Haas and 
Greene, 1988; Schubert, 1988; Stone, 1089; Stone and 
Simmonds, 1991). The nucleoside is able to inhibit activity 
via receptors located on both presynaptic and postsynaptic 
sites. At the former, adenosine reduces the release of a 
number of neurotransmitters including glutamate (Corradetti 
et al. , 1984; Fastbom and Fredholm, 1985), acetylcholine
(Spigonoli et al.,1984), 5-hydroxytryptamine (Feuerstein et 
al., 1985) and dopamine (Michaelis et al., 1979), an effect 
which is thought to be mediated either by a reduction of 
calcium influx into synaptic terminals or by a suppression 
of intracellular calcium availability to the exocytotic 
release process (Silinsky, 1986; Schubert, 1988).
The postsynaptic actions of adenosine include the 
ability to hyperpolarise neurones. In several studies 
evidence has been obtained that this is achieved primarily 
by the activation of potassium conductances, both in 
hippocampal and striatal neurones (Trussel and Jackson, 
1987; Li and Henry, 1992; Thompson et al., 1992).
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In the CNS, the type of potassium channel activated by 
adenosine is unclear. Barium can block the adenosine- 
activated potassium conductance in the rat hippocampus 
(Thompson and Gahwiler, 1992) but barium is a non-selective 
potassium channel and can block several K+ currents such as 
Ip IKATp and Ijj (Cook, 1988; Quayle et al. , 1988). Most
recently, it has been reported that adenosine-induced 
hyperpolarisation is depressed by glibenclamide, a blocker 
of ATP-sensitive K+ channels, in rat CA1 neurohes (Li and 
Henry, 1992) .
GABA is one of the most important inhibitory 
neurotransmitters in the central nervous system (Krnjevic, 
1974, 1987; Sivilotti and Nistri, 1991) and its receptors 
have been classified into two types. GABAA receptors are 
located predominantly on the postsynaptic membranes of 
supraspinal neurones, and usually mediate a bicuculline- 
sensitive hyperpolarisation resulting from an increase of 
chloride conductance (McCormic, 1989; Sivilotti and Nistri, 
1991). The GABAg receptors, in contrast, are located pre-and 
postsynaptically and induce inhibition of transmitter 
release and hyperpolarisation mediated by potassium 
channels (Thompson and Gahwiler, 1992; Deisz et al., 1993).
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Recent evidence has indicated that, besides acting on 
potassium currents, adenosine may also affect chloride 
movements in hippocampal neurones (Mager et al. , 
1990,1995). The present study was therefore designed to 
examine the effect of adenosine alone, and in combination 
with the GABA^ agonist muscimol, on evoked potentials in rat 
hippocampal slices in the presence of barium and 
tolbutamide , a K^p blocker to remove the influence of 
adenosine or GABA effects mediated through potassium 
channels (Li and Henry et al. , 1992; Thompson and Gahwiler, 
1992; Thompson et al., 1992).
The objective of this part of the project was to 
determine whether adenosine had activity at chloride 
channels which would be apparent at the level of population 
potent ials.
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3.2. RESULTS
3.2.1. Effect of adenosine on orthodromic population spikes 
Adenosine concentrat ion-dependently abolished or
reduced the amplitude of the population spike (P.S.) of 
orthodromic CA1 field potentials. A concentration-response 
curve for this effect is shown in figure 3.1. The 
depressant effect of adenosine was readily reversible and 
washed out in about 5 minutes. The threshold concentration 
for adenosine was 1 and 20 pM abolished the population 
spikes. Tachyphylaxis or refractoriness was not seen with 
repeated treatment of adenosine. Adenosine had no effect on 
the presynaptic fibre volley.
3.2.2. Effect of adenosine on orthodromic population spikes 
in the presence of barium 1 mM
In order to exclude the involvement of potassium
channels, and to isolate possible effects on chloride
channels, most experiments were performed in the presence
of barium, 1 mM. In the presence of this concentration of 
barium, the concentration-response curve to adenosine was 
displaced to the right (figure 3.2.). Responses to
adenosine at 2 |iM were completely blocked by barium and 
this submaximal concentration was selected for use in the 
combination experiments described below.
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Figure 3.1. Concentration-response curve for the depression 
of orthodromically evoked CA1 population spike (P.S.) by 
adenosine. Each point represents the mean ± s.e.m. for n=6 
experiments. A paired t test was employed to determine the 
significance level (*P<0.05; M,P<0.001).
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Figure 3.2. Concentration-response curves for the 
depression of orthodromicaliy evoked CA1 population spike 
(P. S.) by adenosine (v) and adenosine+barium 1 mM (▼). Each 
point represents the mean ± s.e.m. for n = 6 experiments.
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3.2.3. Effect of barium and 8-cyclopentyl-l,3- 
dimethylxanthine (CPT) on orthodromic population 
spikes
The inclusion of barium itself in the perfusion medium 
increased the size of the population spikes by 27.36% ± 
0.87 (mean ± s.e.m., P < 0.001, n = 5)(figure 3.3.). 
Superfusion of slices with 8-cyclopentyl-1,3- 
dimethylxanthine (CPT) at 100 nM, resulted in an increase 
of population potential by about 10% (figure 3.3.). Barium 
alone produced an increase of 27%, but the combined 
application of barium and CPT yielded an increase of only 
9.56% ± 0.46, a change which was significantly different 
from control potentials (P < 0.001, n = 5) but not
different from CPT alone.
3.2.4. Effect of baclofen and CPT on population spikes
Baclofen concentration-dependently decreased the size 
of population spikes evoked in the CA1 region by 
orthodromic stimulation (figure 3.4.). The maximum effect 
was observed at 4 |iM which abolished the potential 
completely. The effects of this GABAg agonist were fully 
developed in less 10 minutes and recovery from a single 
concentration on washout occurred in a similar time.
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Baclofen, like adenosine, had no effect on the 
presynaptic fibre volley. However, the potency of baclofen 
on reduction of orthodromic potentials was much greater 
than adenosine.
CPT, an adenosine Aj receptor antagonist, decreased the 
inhibitory effect of baclofen 4 on population spikes to 
72.75 ± 2.287 (P < 0.001, n=4)(figure 3.5).
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Figure 3.3. Increase of orthodromically evoked CA1
population spikes by CPT 100 nM, barium 1 mM and barium 
ImM + CPT 100 nM. Each vertical bar represents the mean ± 
s.e.m. for n=5. A paired t test was employed to determine 
the significance level (***P < 0.001). The horizontal line 
in this and subsequent figures indicates the level of 
significance between columns.
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Figure 3.4. Depression of orthodromically evoked CAl 
population spikes by baclofen. Each vertical bar represents 
the mean ± s.e.m. for n=4. A paired t test was employed to 
determine the significance level (m P<0.001).
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Figure 3.5. Depression of orthodromically evoked CA1 
population spikes by baclofen 4 pM , CPT 100 nM and 
baclofen 4 pM + CPT 100 nM. Each vertical bar represents 
the mean ± s.e.m. for n=4. A paired t test was employed to 
determine the significance level (*P<0.05; m P<0.001).
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3.2.5. Interaction of adenosine and barium on orthodromic 
field EPSPs
The population EPSP recorded in stratum radiatum was 
also reduced by adenosine. At 20 pM adenosine the 
potentials were reduced by 39.92% ± 2.77(P < 0.001, n = 5) 
while in the presence of barium the reduction was 41% ± 
3.85 (not different from adenosine alone (n=5) (figure 
3.6.). Since barium itself tended to increase the size of 
the potential, the combination with adenosine was tested 
with and without any adjustment of the stimulation current 
to restore the potential size in barium to control size. In 
neither case did barium modify the sensitivity of the EPSP 
to adenosine (figure 3.6.).
3.2.6. Effect of muscimol on population spikes
Muscimol induced a concentration-dependent reduction 
in the amplitude of orthodromic population potentials. The 
maximum effect was seen at a concentration of 10 pM. The 
effects of muscimol were fully developed in less than 10 
minutes and no desensitization was noted with different 
concentrations of muscimol(figure 3.7.).
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Figure 3.6. Depression of population EPSP size by adenosine 
20 pM (Ad) and adenosine 20 jjlM + barium 1 mM. The second 
column indicates the effect of adenosine in the presence of 
barium when the stimulus strength was reduced to negate the 
increase of EPSP size produced by barium and thus restore 
the control potential size to that in the absence of 
barium. The third column indicates the adenosine response 
when the stimulus strength was not adjusted. Each vertical 
bar represents the mean ± s.e.m. for n = 5. A one-way
analysis of variance test and Tukey-Kramer multiple 
comparisons test were employed to determine the 
significance level (*P<0.05,***P<0.001).
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Figure 3.7. Concentration-response curve for the depression 
of orthodromically evoked CA1 population spikes (P.S.) by 
muscimol. Each point represents the mean ± s.e.m. for n=5.
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3.2.7. Interaction of adenosine and muscimol on population 
spikes
A submaximal concentration of 1 iiM was selected for 
combination experiments. When this concentration of 
muscimol was combined with a series of concentrations of 
adenosine (figure 3.8.), the depression of the population 
potentials in the presence of both agents was significantly 
greater (P < 0.05) at each adenosine concentration than the 
predicted additive response (figure 3.8.).
3.2.8. Effect of CPT on potentiative interaction between 
adenosine and muscimol in the presence of barium
It was found that CPT at 100 nM would antagonise 
completely responses to adenosine, 2 pM, without any effect 
upon responses to muscimol, 1 piM. Similarly, inclusion of 
barium at 1 mM blocked fully the response to adenosine but 
had no effect whatever on sensitivity to muscimol (figure
3.9.,3.10.). However, when adenosine, 2 pM was combined 
with muscimol, 1 pM in the presence of barium, a very 
marked potentiation was seen leading to a doubling of 
response size (figure 3.9.,3.10.). The additional inclusion 
of CPT then restored this response to that observed in the 
presence of muscimol alone, indicating that the 
potentiation involved the activation of adenosine 
receptors.
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Figure 3.8. Concent ration-response curves for the 
depression of orthodromically evoked CA1 population spikes 
(P.S.) by different concentrations of adenosine and 
adenosine + muscimol 1 pM. Each point represents the mean 
± s.e.m. for n = 5.
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Figure 3.9 Histogram showing depression of orthodromically 
evoked CA1 population spikes by adenosine 2 pM (Ad), 
adenosine 2 pM + CPT 100 nM, muscimol 1 pM, adenosine 2 pM 
+ Ba 1 mM, muscimol 1 pM + Ba 1 mM, adenosine 2 pM+muscimol 
1 pM + Ba 1 mM and adenosine 2 pM + muscimol 1 pM + Ba 1 mM 
+ CPT 100 nM. Each vertical bar represents the mean ± 
s.e.m. for n=5. A one-way analysis of variance test and 
Tukey-Kramer multiple comparisons test were employed to 
determine the significance level (**P<0 . 01 ; ***P<0 .001) .
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3.2.9. Effect of adenosine and muscimol on orthodromic 
field EPSPs
In separate experiments the effect of combined 
applications of adenosine and muscimol were studied on the 
presynaptic terminals. Adenosine at 10 or 20 pM produced a 
submaximal depression of the amplitude of population EPSPs. 
Muscimol at 1 or 2 pM had no significant effect of its own 
on these potentials and did not modify the responses to 
adenosine (figure 3.11.).
3.2.10. Interaction of somatic or dendritic application of 
adenosine and muscimol in the presence of barium
Adenosine was effective in reducing orthodromic 
potentials either at the soma region or in the dendritic 
tree, whereas muscimol was only effective in the soma 
region at 1 and 2 pM concentrations. No significant 
interaction was observed between adenosine and muscimol in 
the dendritic area.
However, in the presence of barium 1 mM, a significant 
positive interaction between adenosine 2 pM and muscimol 1 
pM was seen when they were applied in the somatic region 
(figure 3 . 12.,3.13.).
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Figure 3.11. Depression of the field EPSP by adenosine 10 
PlM, adenosine 20 pivl, muscimol 1 pM, muscimol 2 pM, 
adenosine 10 pM + muscimol 1 pM and adenosine 20 pM + 
muscimol 1 pM. Each vertical bar represents the mean ± 
s.e.m. for n = 4. A one-way analysis of variance test and 
Tuky-Kramer multiple comparisons test were employed to 
determine the significance level (*M P<0.001).
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Figure 3.12. Histogram showing the effect of dendritic 
local microinjection of adenosine and muscimol on 
orthodromic population spikes. Each vertical bar represents 
the mean ± s.e.m. for n=4. A paired t test was employed to 
determine the significance level (***P<0 . 001) .
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Figure 3.13. Histogram showing the effect of somatic local 
microinjection of adenosine and muscimol in the presence of 
barium 1 mM on orthodromic population spikes. Each vertical 
bar represents the mean ± s.e.m. for n=4. A paired t test 
was employed to determine the significance level 
(m P<0.001) .
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3.2.11. Effect of 4,4’-diisothiocyanotostilbene-
2,2’disulfonic acid on potentiative interaction 
between adenosine and muscimol
During superfusion with the chloride channel blocker 
4,4*-diisothiocyanatostilbene-2,2-disulfonic acid (DIDS) at 
100 m-M, population spike size was increased slightly, but 
significantly, by 6.28% ± 0.38 (P < 0.001, n = 5). In 
addition, DIDS proved able to reduce significantly the 
depressant effects of adenosine, 2 or 5 |iM (figure 3.14.), 
and block the inhibitory effect of muscimol, 1 or 2 (j,M on 
population spike size (figure 3.15.).
In order to determine whether the action of adenosine 
could be accounted for entirely in terms of the blockade of 
barium-sensitive potassium current and DIDS-sensitive 
chloride channels, the effect of combining these was 
examined. At a concentration of 10 |xM adenosine, which 
induced approximately 50 % inhibition of population
potential size, the combination of barium 1 mM and DIDS 100 
liM was significantly more effective than either agent alone 
in antagonising adenosine; adenosine responses were reduced 
by about 70 % compared with responses in barium alone 
(figure 3.16.). However, a residual sensitivity to 
adenosine was clearly present. When the concentration of
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adenosine used was almost maximal, 20 piM, the additional 
presence of DIDS caused less inhibition, around 45 %, and 
the residual response to adenosine was correspondingly 
greater (figure 3.16.)* The sequence of combinations 
reported above was therefore repeated on a different set of 
slices, but with the addition of a combination with DIDS. 
As above, barium blocked responses to adenosine, but not 
muscimol, and a potentiation was then obtained with 
adenosine and muscimol in the presence of barium, yielding 
here an inhibition of population potential of 30.85% ± 0.5. 
The addition of DIDS now abolished this potentiation and 
reduced the degree of inhibition of the combination by 
about 60 % (n=4) (figure 3.16.,3.17.,3.18.).
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Figure 3.14. Depression of orthodromically evoked CA1 
population spikes by different concentrations of adenosine 
alone and in the presence of DIDS 100 pM. Each vertical bar 
represents the mean ± s.e.m. for n = 4. A one-way analysis 
of variance test and Tuky-Kramer multiple comparisons test 
were employed to determine the significance level 
(m P<0.001) .
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Figure 3.15. Depression of orthodromical ly evoked CA1 
population spikes by different concentrations of muscimol 
alone and in the presence of DIDS 100 |iM. Each vertical bar 
represents the mean ± s.e.m. for n = 4. A one-way analysis 
of variance test and Tuky-Kramer multiple comparisons test 
were employed to determine the significance level (**P < 
0.01 ; ***P < 0.001) .
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Figure 3.16. Histogram showing the depression of 
orthodromically evoked CA1 population spikes by adenosine, 
adenosine + barium and adenosine + barium + DIDS. Except 
for the first two columns, the changes of potential size 
were measured with respect to their amplitude in 1 mM 
barium. Each vertical bar represents the mean ± s.e.m. for 
n = 4. A one-way analysis of variance test and Tuky-Kramer 
multiple comparisons test were employed to determine the
ttt
significance level ( P<0.001).
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Figure 3.17. Depression of orthodromically evoked CA1 
population spikes by adenosine 2 ijlM, muscimol 1 pM, 
adenosine 2 pM + Ba 1 mM, muscimol 1 pM + Ba 1 mM, 
adenosine 2 pM+musciraol 1 pM + Ba 1 mM and adenosine 2 pM 
+ muscimol 1 pM + Ba 1 mM + DIDS 100 pM. The data are taken 
from a different set of experiments to those summarised in 
Fig.3.9. Except for the first 2 columns, the changes of 
potential size were measured with respect to their 
amplitude in 1 mM barium. Each vertical bar represents the 
mean ± s.e.m. for n = 4. The letters below the columns 
refer to the sample records illustrated in Fig.3.18. A one­
way analysis of variance test and Tuky-Kramer multiple 
comparisons test were employed to determine the 
significance level (**P<0.01; m P < 0.001).
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3.2.12. Interaction of adenosine and tolbutamide on 
orthodromic population spikes
Adenosine at 2, 5 and 10 pM reduced the amplitude of
orthodromic population spikes by 12.75% ± 1.11 (P<0.001,
n=4), 28.50% ± 1.44 (P<0.001, n=4) and 55.25% ± 2.29
(P<0.001, n=4) respectively. Tolbutamide 1 mM alone
increased the population spikes by 12.13% ± 1.39 (P<0.01, 
n=4) . This effect was seen in less than 10 minutes. The 
inhibitory effect of adenosine 2 pM was completely blocked 
by tolbutamide 1 mM. In addition to this, tolbutamide 1 mM 
significantly decreased the effect of adenosine 5 and 10 pM 
to 22.38% ± 1.40 (P<0.05, n=4) and 37.50% ± 2.60 (P<0.01, 
n=4)(figure 3.19.).
3.2.13. Interaction of adenosine and tolbutamide on 
orthodromic field EPSPs
The inhibitory effect of adenosine was less on fEPSP 
size than population spike size. However, tolbutamide 1 mM 
did not affect this presynaptic effect of adenosine. 
Tolbutamide alone increased the size of field EPSP by 6.03% 
± 1.61 (P<0.05, n=4)(figure 3.20.).
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Figure 3.19. Histogram showing the effect of adenosine and 
tolbutamide on orthodromically evoked CA1 population 
spikes. Each vertical bar represents the mean ± s.e.m. for 
n = 4. A paired t test was employed to determine the 
significance level (**P<0.01; m P < 0.001).
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Figure 3.20. Histogram showing the effect of adenosine and 
tolbutamide on orthodroraically evoked CA1 field EPSPs. Each 
vertical bar represents the mean ± s.e.m. for n = 4. A 
paired t test was employed to determine the significance 
level (*P<0 . 05 ; m P < 0.001).
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3.2.14. Interaction of adenosine and muscimol in the 
presence of tolbutamide 1 mM
Adenosine 2 pM and muscimol 1 pM reduced the amplitude 
of orthodromic population spikes by 12.75% ± 1.10 (P<0.001, 
n=4) and 13.375% ± 1.02 (P<0.001, n=4) respectively. In the 
presence of tolbutamide 1 mM, adenosine 2 pM had no 
significant effect on the population spike size, whereas 
muscimol reduced the spike size by 13.5% ± 0.64 (P<0.001, 
n=4) .
Combination of adenosine 2 uM and muscimol 1 pM in the 
presence of tolbutamide showed a potentiative interaction 
and reduced the spike size by 29.5% ± 1.848 (P<0.001, n=4) 
(figure 3.21.).
3.2.15. Antidromic extracellular recording
It should be mentioned that the initial protocol to 
exclude potassium channels of adenosine and to show the 
possible residual effect of adenosine at the postsynaptic 
site, was to employ the antidromic extracellular technique. 
However, barium showed calcium-mimitic features on 
antidromic spikes and abolished them in less than three 
minutes. Because of this effect of barium in the antidromic
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technique, the initial protocol was changed to the 
orthodromic technique.
3.2.16. Effect of adenosine on antidromic bursts induced in 
calcium-free medium with added magnesium (4 mM)
Adenosine concentration-dependently decreased or 
abolished secondary spikes in calcium-free high magnesium 
(4 mM) (figure 3.22.). Adenosine at a concentration of 20 
pM, (the same concentration that abolished the orthodromic 
population spikes in normal ACSF) completely abolished the 
antidromic bursts in calcium-free medium high magnesium 
(figure 3.22.,3.23.).
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Figure 3.21. Depression of orthodromically evoked CA1 
population spikes by adenosine 2 pM, muscimol 1 pM, 
adenosine 2 pM + tolbutamide 1 mM, muscimol 1 pM + 
tolbutamide 1 mM and adenosine 2 pM + muscimol 1 pM + 
tolbutamide 1 mM. Except for the first 2 columns, the 
changes of potential size were measured with respect to 
their amplitude in 1 mM tolbutamide. Each vertical bar 
represents the mean ± s.e.m. for n = 4. A one-way analysis 
of variance test and Tuky-Kramer multiple comparisons test 
were employed to determine the significance level (,MP < 
0 .0 0 1 ) .
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Figure 3.22. concentration-response curve for the effect of 
adenosine on antidromically induced secondary spikes (S.S.) 
in calcium-free media containing 4 mM magnesium. Each point 
represents the mean ± s.e.m. for n=4. A paired t test was 
employed to determine the significance level (**P<0.01; 
m P<0.001) .
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3.3. DISCUSSION
3.3.1. Interaction of adenosine and muscimol in the 
presence of barium
The results indicate that barium at a concentration of 
1 mM can block the inhibitory effect of adenosine on 
population spike potentials in the hippocampus, without 
altering inhibition of the population synaptic potential 
(EPSP) evoked by stimulation of the Schaffer collateral and 
commissural axons in stratum radiatum. This is entirely 
consistent with recent evidence from intracellular 
recordings that barium will block the postsynaptic, but not 
the presynaptic, effects of adenosine (Thompson and 
Gahwiler, 1992; Thompson et al., 1992).
The failure of barium to modify responses to muscimol 
emphasises the relative selectivity of barium for cation 
channels operated by adenosine, rather than channels 
associated with GABAA receptors.
When applied alone, barium also increased the amplitude 
of the orthodromically evoked population potentials, a 
finding which may reflect the blockade of potassium 
channels involved in transmitter mediated tonic inhibition 
of postsynaptic excitability. A contribution of endogenous
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adenosine to this background inhibition was suggested by 
the finding that CPT also increased the population spikes 
(Bauman et al., 1992; Gribkoff and Bauman, 1992), an effect 
which probably results from the blockade of adenosine 
receptors at both presynaptic and postsynaptic sites. A 
component of the increased baseline size in barium could be 
due to a release of endogenous excitatory amino acids 
(McMahon and Nicholls, 1993).
The greater effect of barium (compared with CPT) on 
baseline potential size may reflect some blockade of 
channels associated with other tonically active receptors, 
such as GABAg or acetylcholine. Nevertheless, it might be 
expected that superfusion of slices with a mixture of 
barium and CPT would increase potential size to at least an 
additive degree. However, the combined effect was no 
greater than that obtained with CPT alone, and was 
substantially less than that obtained with barium alone but 
CPT proved able to decrease the inhibitory effect of 
baclofen as well. One possibility is that, CPT besides 
blocking the effect of adenosine, can block the other 
potassium channels. Thus, after application of CPT, there 
are no potassium channels to be affected by barium. 
Alternatively, since divalent cations are known to modulate 
binding to Aj adenosine receptors, barium may be preventing 
the binding of CPT to receptors.
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The major finding of this study was the observation that 
adenosine, in the presence of a sufficient concentration of 
barium to block fully responses to the purine alone at 2 
pM, could markedly potentiate responses to muscimol, the 
combined response being approximately 100% greater than to 
muscimol alone.
The involvement of Aj adenosine receptors in this 
potentiation was confirmed by the ability of CPT, a 
selective antagonist at Aj receptors, to prevent the 
potentiation and restore the effect of the combination to 
that of muscimol alone. The implication of these findings 
is that there is a population of adenosine receptors which 
is able to potentiate the activation of GABAA receptors, but 
which is not coupled to barium-sensitive potassium 
channels. It should be emphasized that the potentiative 
interaction between adenosine and muscimol appears to be 
confined to the postsynaptic membrane. No interaction 
between adenosine and muscimol 1 and 2 pM was observed when 
these were tested on population EPSPs as a reflection of 
their activity at presynaptic receptors. Furthermore, 
microinjection experiments confirm that muscimol, at 
concentrations which were applied in this study, has no 
effect in the dendritic tree, whereas it has a significant 
inhibitory effect on the somatic region. This finding is
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consistent with the previous experiment which indicates 
that the interaction of adenosine and muscimol occurs at 
the postsynaptic site.
The chloride channel blocker DIDS was able to reduce 
the inhibitory activity of muscimol, consistent with the 
generally accepted view that GABAA receptors induce 
hyperpolarisation primarily by opening chloride channels 
(Bormann, 1988). The same concentration of DIDS, however, 
also proved able to prevent the inhibitory activity of 
adenosine. This reduction of responses to adenosine by DIDS 
strongly supports the view that adenosine can exert part of 
its inhibitory activity on postsynaptic neurones by 
enhancing chloride fluxes. This idea arose initially from 
observations that chloride channel blockers could interfere 
with the change of calcium movement induced by purines or 
xanthines in hippocampal slices (Mager et al. , 1990),
although effects of purines on chloride movements have been 
reported in other tissues, such as airway epithelial cells 
(Rugolo et al., 1993).
When a combination of barium and DIDS was present the 
suppression of adenosine responses was, as expected, 
significantly greater than with either channel blocker 
alone. However, a residual response was seen with adenosine
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which was proportionately greater at a higher 
concentration. This may indicate that higher concentrations 
can also activate populations of barium-insensitive or DIDS 
insensitive channels.
The results further indicate that the potassium- 
independent potentiation noted with the combination of 
adenosine and muscimol in the presence of barium is partly 
mediated by chloride channels, since the potentiated 
response was reduced by more than 60% following the 
addition of DIDS.
These data do not allow any definitive statement of the 
relationship between muscimol and adenosine activated 
chloride channels. However, since a combination of the two 
agents produced a potentiated effect on inhibition, it is 
possible that two distinct populations of channels are 
involved.
3.3.2. Interaction of adenosine and muscimol in the 
presence of tolbutamide
ATP-sensitive potassium channels constitute a new class 
of potassium channels that link membrane potentials to the 
bioenergetic status of the cell. An increase in the
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intracellular concentration of ATP tends to close this 
channel and produce depolarisation (Bernardi and 
Lazdunski, 1993). In pancreatic cells, where channel
function is relatively well understood, depolarisation
induced by elevated ATP levels, subsequent to glucose
2+metabolism, opens voltage-gated Ca channels to release 
insulin. Sulphonylurea compounds, such as tolbutamide or 
glibenclamide, can block this potassium channel and trigger 
insulin release (Gopalakrishnan et al. , 1993). The
existence of sulphonylurea binding sites associated with 
ATP-sensitive K channels have been shown in the hippocampus 
and other parts of brain (Mourre et al., 1989).
Hypoglycaemia or hypoxia in CNS can activate KATp as a 
neuroprotective mechanism of neuronal cells. For example 
during anoxia, when cellular levels of ATP decline, these 
channels are activated and can block glutamate release 
(Zini et al., 1993).
The results indicate KATp channel involvement in the 
postsynaptic effect of adenosine and are consistent with a 
report that an inhibitory postsynaptic potential in spinal 
nociceptive neurones, apparently mediated by adenosine, was 
blocked by glibenclamide (Salter et al. , 1993). The present 
result is also consistent with the block of adenosine-
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induced hyperpolarisation by glibenclamide in the 
hippocampus (Li and Henry, 1992). The fact that tolbutamide 
had no effect on the presynaptic action of adenosine may 
indicate a totally different mechanism for the pre- and 
postsynaptic effects. The possible existence of different 
types of potassium channels activated by adenosine at pre- 
and postsynaptic sites cannot be excluded.
The results show that tolbutamide, at a concentration of
1 mM, like barium can block the inhibitory effect of 
adenosine 2 pM on population spike potentials, whereas it 
is not able to modify responses to muscimol, suggesting the 
selectivity of tolbutamide for adenosine-activated 
potassium channels, rather than channels associated with 
GABAa receptors.
Similar to the barium experiments, it was observed that 
adenosine, in the presence of a sufficient concentration of 
tolbutamide to block fully responses to purine alone at
2 pM, could markedly enhance responses to muscimol, the 
combined response being approximately 100% greater than to 
muscimol.
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The interaction demonstrated here may help to explain 
the interactions which have been reported or postulated 
between purines and benzodiazepines in the CNS (Phillis, 
1979; Phillis et al., 1979; Sierralta and Miranda, 1993). 
They may also explain the observation that the systemic 
administration of the Aj selective agonist 2-chloro-N6- 
cyclopentyladenosine induces a 44% increase in the binding 
affinity of the chloride channel ligand t- 
butylbicyclophosphorothionate (TBPS) in mouse neocortex 
(Concas et al. , 1993). This effect was prevented by 1,3-
dipropyl-8-cyclopentylxanthine, supporting a role for Aj 
receptors.
In summary, this study has revealed that the activation 
of DIDS-sensitive chloride channels on hippocampal CA1 
pyramidal neurones contributes to the inhibitory effect of 
adenosine on population evoked potentials. This activity 
can lead to a potentiation of responses to GABAA receptor 
activation. Adenosine’s activation of chloride channels may 
thus contribute both directly and indirectly to the overall 
control of neuronal excitability.
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Potentiation by neurosteroids of 
muscimol/adenosine interaction in rat
hippocampus
4.1. Introduction
GABA is an inhibitory neurotransmitter which is abundant 
in the vertebrate central nervous system (Sivilotti and 
Nistri, 1991; Veenmaan and Reiner, 1994). There is abundant 
evidence in favour of this hypothesis, including the 
presence of specialized neurons that synthesize, contain 
and release GABA; physiological actions of GABA mimic those 
of electrical activation of local circuit interneurons and 
inhibitory postsynaptic potentials (IPSPs) can be blocked 
by selective GABA antagonists (Iversen et al. , 1971; Avoli, 
1986; Connors et al., 1988).
At least two distinct GABA receptors have been
identified, classified as GABAA and GABAg (Bormann, 1988).
1 0 +
The GABAg receptor subtype is linked to K or Ca channels 
by second messenger systems which induce GTP binding 
proteins. The activation of GABAg receptors inhibits 
transmitter release presynaptically or hyperpolarises 
neurons, postsynaptically (Deisz et al; Kuriyma et al., 
1993). Synaptically released GABA binds to GABAA receptors 
in the post synaptic membrane and causes an increase in Cl' 
conductance and hyperpolarises the cells (Bormann et al. , 
1987) .
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The GABAa receptor complex consists of several 
polypeptide subunits which form a hetero-oligomeric 
chloride channel and provide binding sites at least for 
benzodiazepines, barbiturates, steroids and ethanol (Olsen 
and Tobin, 1990; Aguyo and Alurcon, 1993).
In 1941 Selye reported the anaesthetic and sedative 
properties of steroids like progesterone. There are both 
inhibitory and excitatory steroids that respectively, 
promote or inhibit GABA activity, at GABAA receptors. 
Specific brain neurosteroids which are synthesized in glial 
cells and some synthetic steroids allosterically modulate 
GABA gated Cl" channels. These steroids potentiate both 
benzodiazepine and muscimol binding whereas, they inhibit 
t h e  b i n d i n g  of t h e  c o n v u l s a n t  t - 
butylbicyclophosphorothionate (TBPS). It has been reported 
that alphaxalone and 5a-pregnan-3a-ol-20-one are positive 
modulators of the GABAA receptors (Harrison and Simmonds, 
1984; Cottrell et al. , 1987; Harrison et al. , 1987; Peters 
et al., 1988; Turner and Simmonds, 1989). They have been
shown to have two distinct action on the GABAA receptors. At 
low concentrations, they potentiate the GABAA action, while 
at higher concentrations they can directly open the 
chloride channel associated with the GABAA receptors 
(Majewska et al., 1986; Puia et al., 1991).
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Adenosine is a potent inhibitor of neuronal activity in 
the central and peripheral nervous system (Dunwiddie, 1985; 
Stone, 1985; Nicoll et al. , 1990). As a neuromodulator
adenosine has a profound depressant action in the central 
nervous system. The mechanism of adenosine is not fully 
understood. However, the action of adenosine may be 
mediated pre- and postsynaptically through receptor 
mediated mechanisms including effects on second messenger 
systems, transmembrane ion fluxes and neurotransmitter 
release (Greene and Haas, 1991; Stone and Simmonds, 1991). 
Although the mechanism of presynaptic inhibition is not
well known, adenosine may inhibit transmitter release by
2+reducing voltage-dependent Ca current, activating
2+potassium current or by mechanisms downstream to Ca influx 
(Greene and Haas, 1991; Thompson et al., 1992). At
postsynaptic sites, adenosine and its analogs activate 
potassium currents (Trussel and Jackson, 1985; Gerber et 
al., 1989; Thompson et al., 1992).
Adenosine receptors have been categorized into three 
major subtypes (Aj, A 2 , A3) , according to their effect on 
adenylate cyclase and on the basis of agonist structure- 
activity relations and the use of a range of xanthine and 
non-xanthine antagonists (Stone, 1985,1991; Vangalen et 
al., 1992; Gurden et al., 1993). However, some effects of
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adenosine may not be mediated by changes in cyclic AMP 
levels (Scott and Dolphin, 1987).
Adenosine has been shown to have many effects on the 
CNS, including sedation, anti convulsant action and 
protection against ischemia (Greene and Haas, 1991). There 
is growing evidence that besides acting on potassium and 
calcium currents, adenosine may also affect chloride 
movement in hippocampus neurons ( Mager et al., 1990,1995). 
In addition to this, several effects of benzodiazepines are 
antagonized by theophylline and caffeine which are 
adenosine receptor antagonists (Pole et al., 1981).
It was shown (chapter 3) that the effect of muscimol on 
population spike size was enhanced by adenosine while the 
adenosine activated potassium channels were blocked by 
barium 1 mM or tolbutamide 1 mM. Moreover, DIDS a chloride 
channels blocker (Miller and White, 1984) and CPT 
(cyclopenthyltheophyl1ine) an adenosine Aj receptor 
antagonist, decreased this potentiative interaction 
(Chapter 3).
In this part of the project, the effect of allosteric 
modulatory steroids was examined on the inhibitory effect 
of adenosine, muscimol and on the potentiative interaction 
between adenosine and muscimol.
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4.2. Results
Of the various neurosteroids that are positive 
modulators of GABAA receptors, alphaxalone was selected as 
a synthetic neurosteroid and 5a-pregnan-3a-ol-20-one as an 
endogenous neurosteroid. Both agents have been shown to 
potentiate the inhibitory effect of GABAA at low 
concentrations while at high concentrations, like 
barbiturates, they are able to act directly on the GABAA 
chloride channel.
4.2.1. Effect of alphaxalone on orthodromic population 
spikes
At low concentrations of 0.5 and 1 pM alphaxalone had 
no significant effect on the orthodromic population 
potential size. Higher concentrations of 3, 5 and 10 pM, 
however, reduced spike size significantly by up to 16% 
(figure 4.1.).
4.2.2. Effect of 5a-pregnan-3a-ol-20-one on orthodromic 
population spikes
At a low concentration of 0.5 pM, 5a-pregnan-3a-ol- 
20-one had no effect on population spike size. Higher 
concentrations of 1, 5 and 10 pM reduced spike size
significantly by up to 23% (figure 4.2).
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Figure 4.1. Depression of orthodromically evoked CA1 
population spikes (P.S.) by alphaxalone. Each vertical bar 
represents the mean ± s.e.m. for n = 4 experiments. A 
paired Student’s t-test was employed to determine the 
significance level (*P<0.05, m P<0.001).
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Figure 4.2. Depression of orthodromically evoked CA1 
population spikes (P.S.) by 5a-pregnan-3cc-ol-20-one 
(allopregnan). Each vertical bar represents the mean ± 
s.e.m. for n = 4 experiments. A paired Student’s t-test was 
employed to determine the significance level (*P<0.05, 
*M P<0.001).
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4.2.3. Interaction of alphaxalone and muscimol on 
orthodromic population spikes
Muscimol 1 pM reduced spike size by 13.97% ± 0.65
(P<0.001, n = 4) . Alphaxalone 0.5 and 1 m-M, concentrations 
that had no significant effect on the spike size,
potentiated the inhibitory effect of muscimol to 20.82% and 
32.50%. Although alphaxalone at 5 pM exerted a direct
inhibition of spike size, it also potentiated the effect of 
muscimol significantly (figure 4.3.,4.4.).
4.2.4. Interaction of 5a-pregnan-3a-ol-20-one and muscimol 
on orthodromic population spikes
5a-pregnan-3a-ol-20-one 0.5 and 1 uM potentiated the
inhibitory effect of muscimol to 23.50% and 37.18% (figure 
4.5.).
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Figure 4.3. Depression of orthodromically evoked CA1 
population spikes (P. S.) by muscimol 1 pM, alphaxalone and 
muscimol 1 pM + alphaxalone. Each vertical bar represents 
the mean ± s.e.m. for n = 4 experiments. A paired Student’s 
t^test was employed to determine the significance level 
(**P<0.01, MIP<0.001).
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Figure 4.5. Depression of orthodromically evoked CA1 
population spikes (P. S.) by muscimol 1 |iM, 5a-pregnan-3a- 
ol-20-one (allopregnan) and muscimol 1 pM + allopregnan. 
Each vertical bar represents the mean ± s.e.m. for n = 4 
experiments. A paired Student’s t-test was employed to 
determine the significance level (m P<0.001).
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4.2.5. Interaction of alphaxalone and adenosine on
orthodromic population spikes
Adenosine 2 |iM reduced the spike amplitude by 12.85% ± 
0.53 (P<0.001, n = 4). Alphaxalone at 1 uM, a concentration 
without any significant effect on the spike size 
potentiated the inhibitory effect of adenosine 
significantly. The combination of adenosine 2 uM and 
alphaxalone 5 |iM reduced the spike size by 41.00% ± 1.29 
(P<0.001, n = 4) (figure 4.6.,4.7.).
In order to exclude the role of adenosine activated 
potassium channels in these interactions, these experiments 
were repeated in the presence of barium 1 mM. In the 
presence of barium, adenosine 2 *iM became ineffective, 
whereas alphaxalone 5 |iM still reduced the spike amplitude 
by 9% ± 0.37 (P<0.001, n = 4) . The combination of adenosine 
2 pM with alphaxalone 1 and 5 pM in the presence of barium 
reduced the spike size by 5.90% and 20.13% respectively 
(figure 4.8.).
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Figure 4.6. Depression of orthodromically evoked CA1 
population spikes (P. S.) by adenosine 2 pM, alphaxalone
and adenosine 2 uM + alphaxalone. Each vertical bar 
represents the mean ± s.e.m. for n = 4 experiments. A 
paired Student’s t-test was employed to determine the 
significance level (**P<0.01, m P<0.001).
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Figure 4.8. Depression of orthodromically evoked CA1 
population spikes (P. S.) by adenosine 2 pM, alphaxalone, 
adenosine 2 pM + barium 1 mM, alphaxalone + barium \ mM and 
adenosine 2 pM + alphaxalone + barium 1 mM. Each vertical 
bar represents the mean ± s.e.m. for n = 4 experiments. A 
one-way analysis of variance test and Tuky-Kramer multiple 
comparisons tast were employed to determine the 
significance level ($P<0.05, *#P<0.01, m P<0.001).
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4.2.6. Interaction of 5a-pregnan-3a-ol-20-one and adenosine
on orthodromic population spikes
5a-pregnan-3a-ol-20-one 1 and 5 pM potentiated the 
inhibitory effect of adenosine 2 pM significantly (figure 
4.9.). In the presence of barium 1 mM 5a-pregnan-3a-ol-20- 
one 5 pM reduced the population spike size by 10.47% 
(figure 4.10.). The combination of adenosine 2 pM with 5a- 
pregnan-3a-ol-20-one 1 and 5 pM in barium, reduced the 
spike amplitude by 6.10% and 23.20% respectively 
approximately double the response size expected from a 
purely additive interaction (figure 4.10.).
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Figure 4.9. Depression of orthodromically evoked CA1 
population spikes (P. S.) by adenosine 2 5a-pregnan-3a-
ol-20-one (allopregnan) and adenosine 2 pM + allopregnan. 
Each vertical bar represents the mean ± s.e.m. for n = 4 
experiments. A paired Student’s t-test was employed to 
determine the significance level (M P<0.01, m P<0.001).
121
^ A denosine 2 uM
Adenosine 2 uM+Barium 1 mM 
Allopregnan 1 uM+Barium 1 mM 
Allopregnan 5 uM+ Barium 1 mM 
A denosine 2 uM+Allopregnan 1 uM+Barium 1 mM 
Adenosine 2 uM+Allopregnan 5 uM+Barium 1 mM
a>
N
m
m
Dh
<D
C/3
aj
<D
CJ
0)
Q
25
20
15
10
***
0 m r f f n m
***
T
B a r iu m  c o n t r o l
>
Figure 4.10. Depression of orthodromically evoked CA1 
population spikes (P. S.) by adenosine 2 pM, 5ct-pregnan-3a- 
ol-20-one (allopregnan), adenosine 2 pM + barium 1 mM, 
allopregnan + bairum 1 mM and adenosine 2 pM + allopregnan 
+ barium 1 mM. Each vertical bar represents the mean ± 
s.e.m. for n = 4 experiments. A one-way analysis of
variance test and Tuky-Kramer multiple comparisons test 
were employed to determine the significance level (*P<0.05, 
,MP<0.001).
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4.2.7. Effect of combination of adenosine 2 pM and muscimol
1 pM with alphaxalone in the presence of barium 1 mM
In barium, muscimol 1 pM reduced the spike size by
13.32% ± 0.71 (P<0.001, n = 4) while adenosine 2 pM was
ineffective. The combination of muscimol 1 pM with 
adenosine 2 pM reduced the spike size by 29.73% ± 0.83 
(P<0.001, n=4). This reduction was increased significantly 
in alphaxalone 1 and 5 pM to 39.00% ± 1.29 (P<0.01, n=4) 
and 49.50% ± 1.04 (P<0.001, n=4) (figure 4.11.).
4.2.8. Effect of combination of adenosine 2 pM and muscimol
1 pM with 5a-pregnan-3a-ol-20-one in the presence of
barium 1 mM
The combination of adenosine 2 pM and muscimol 1 pM in 
barium reduced the spike size by 30.17% ± 0.98 (P<0.001, 
n=4) . This potentiative interaction was enhanced by 5a- 
pregnan-3a-ol-20-one 1 and 5 pM tO 40% ± 1.87 (P<0.05, n=4) 
and 50.17% ± 3.02 (P< 0.01, n=4 ) respectively (figure
4.12.) .
To determine if these neurosteroids potentiate 
adenosine action directly or through the activating of
endogenous GABA, the experiment with adenosine and 5a-
123
pregnan 3a-ol-20-one was performed in the presence of 
bicuculline 1 pM. Muscimol 1 pM has no effect in the 
presence of bicuculline 1 pM and bicuculline 1 pM increased 
the spike size by 11.75% ± 1.18 (P<0.001, n=4). Agonist
responses were therefore measured using the potential size 
in the presence of bicuculline as the control level. 5a- 
pregnan-3a-ol-20-one 1 and 5 pM did not modify the 
inhibitory effect of adenosine 5 pM in the presence of 
bicuculline 1 pM (figure 4.13.).
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Figure 4.11. Depression of orthodromically evoked CA1 
population spikes (P. S.) by adenosine 2 pM, muscimol 1 pM,
alphaxalone, adenosine 2 pM + barium 1 mM, alphaxalone +
barium, adenosine 2 pM + muscimol 1 pM + barium and
adenosine 2 pM + muscimol 1 pM + alphaxalone 4 barium 1 mM.
Each vertical bar represents the mean ± s.e.m. for n = 4 
experiments. A one-way analysis of variance test and Tuky- 
Kramer multiple comparisons test were employed to determine 
the significance level (**P<0.01, U P<0.001).
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Figure 4.12. Depression of orthodromically evoked CA1 
population spikes (P. S.) by adenosine 2 pM, muscimol 1 pM, 
5a-pregnan-3a-ol-20-one (allopregnan), adenosine 2 pM + 
barium 1 mM, muscimol 1 pM + barium, adenosine 2 pM + 
muscimol 1 pM + bairum and adenosine 2 pM + muscimol 1 pM 
+ allopregnan + barium 1 m M . Each vertical bar represents 
the mean ± s.e.m. for n = 4 experiments. A one-way analysis 
of variance test and Tuky-Kramer multiple comparisons tast 
were employed to determine the significance level (*P<0.05, 
M P<0.01).
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Figure 4.13. Depression of orthodroraically evoked C A 1  
population spikes (P. S . )  by adenosine 2, 5 pM, and
adenosine 5 pM + allopregnan + bicuculline 1 pM. Each 
vertical bar represents the mean ± s.e.m. for n = 4
experiments. A  one-way analysis of variance test and Tuky- 
Kraraer comparisons tast were employed to determine the 
significance level (***P<0 . 001) .
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4.3. Discussion
A vast body of evidence shows that certain synthetic 
and endogenous steroids act as potent modulators at the 
GABAa receptor (Cottrell et al. , 1987; Puia et al., 1991). 
The anaesthetic alphaxalone and some reduced metabolites of 
progesterone like 5a-pregnan-3a-ol-20-one potentiate GABA 
responses (Harrison and Simmonds, 1984; Harrison et al. , 
1987). In contrast, pregnenolone sulfate interacts with the 
GABAa receptor in an antagonistic manner (Majewska et al., 
1986).
Several lines of evidence indicate that the alphaxalone 
and 5a-pregnan-3a-ol-20-one act in a barbiturate-like 
fashion at the GABAA receptors (Majewska et al., 1988). The 
results are in agreement with other reports using 
electrophysiological methods in the CA1 region of the 
hippocampus, and confirm that alphaxalone and 5a-pregnan- 
3a-ol-20-one, at low concentrations that have no 
significant effect on the population spike size, can 
potentiate the GABAA inhibitory effect. At higher 
concentrations they can act on the GABAA associated chloride 
channels directly.
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The interesting finding of this study was interaction 
between the alphaxalone, 5a-pregnan-3a-ol-20-one and 
adenosine. It has previously been shown that, in addition 
to acting on potassium channels, adenosine can affect 
chloride channels (chapter 3). One possible explanation of 
the steroid potentiation of adenosine, therefore, could be 
that they are acting directly at adenosine-operated 
chloride channels.
To isolate the possible interaction of alphaxalone and 
5a-pregnan-3a-ol-20-one with adenosine at the chloride 
channels, the adenosine activated potassium channels were 
blocked with barium 1 mM. It has been previously shown 
barium can block the adenosine potassium channel (Thompson 
et al. ,| 1992 . Under these conditions, alphaxalone and 5a-
pregnan-3a-ol-20-one still potentiated the inhibitory 
effect of adenosine although the effect was less marked 
than without barium, suggesting that some part of that 
interaction was due to the adenosine activated potassium 
channels activity.
To determine if these neurosteroids potentiate 
adenosine inhibitory effect directly or through the 
mediation of GABAA receptors, the GABAA receptor was 
blocked with bicuculline 1 pM. In the presence of
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bicuculline, these neurosteroids failed to potentiate the 
adenosine effect on the population spike size. The results 
therefore suggest that these neurosteroids potentiate the 
adenosine indirectly by potentiating endogenous GABA at 
GABAa receptors. On the other hand, the results are 
consistent with previous reports that showed the chloride 
channels activated by adenosine to be different from those 
operated by GABAA receptors (Mager et al. , 1990,1995).
Collectively, the results indicate that low endogenous 
concentrations of GABA and adenosine could potentiate each 
other sufficiently to exert a significant inhibition of 
neuronal activity in the CNS. Given the capacity of 
endogenous neurosteroids to potentiate GABAA receptor 
activation and thus apparently the GABA/adenosine 
interaction, it seems probable that the level of neuronal 
inhibition will be extremely sensitive to small variations 
in the concentrations of any of these agents.
In conclusion, the potentiation of the adenosine 
inhibitory effect in the presence of barium and enhancement 
of potentiative interaction of adenosine and muscimol by 
alphaxalone and 5a-pregnan-3a-ol-20-one, is a further 
confirmation for the point mentioned in chapter 3, that 
some part of the inhibitory effect of adenosine at
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postsynaptic sites 
channels.
is due to acting on the chloride
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Induction of a novel form of hippocampal 
long-term  depression by muscimol
5.1. Introduction
Synaptic efficacy plays an important role in some 
aspects of hippocampal memory storage (Nicol et al. , 1988; 
Linden, 1994). According to Hebb’s theory of learning, 
memory and learning are thought to be the processes of 
stabilising specific neuronal associations by strengthening 
or weakening synaptic transmission at specific synapses 
(Hebb, 1949).
As one example of synaptic strengthening, the mechanism 
of long-term potentiation (LTP) has been studied 
extensively (Bliss & Lomo, 1973; Bliss & Col1ingridge, 
1993). Although both excitation and inhibition are 
important in controlling neuronal activity, long-term 
depression (LTD) remains poorly documented compared to LTP 
(Stanton & Sejnowski, 1989; Yang & Faber, 1991). Most of 
the work on LTP and LTD has been performed in the CA1 
region of the hippocampus, cerebellar cortex, striatum, 
nucleus accumbens and neocortex (Levy & Steward, 1979; 
Ekerot & Kano, 1985; Ito, 1989; Kimura et al. , 1989;
Stanton & Sejnowski, 1989; Calabresi et al., 1992; Pennartz 
et al., 1993) .
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Glutamate is a major transmitter in the vertebrate 
central nervous system and its receptors have been 
categorized into two group: Ionotropic and Metabotropic.
The ionotropic receptors contain integral, cation-specific 
ion channels, whereas the metabotropic are coupled to G- 
proteins and modulate the intracellular second messenger 
systems (Col1ingridge and Lester, 1989; Monaghan et al. , 
1989; Schoepp et al. , 1990; Miller, 1991; Nakanishi, 1992). 
Metabotropic glutamate receptors have been reported to play 
a critical role in the modulation of different forms of 
neuronal activity in the hippocampus. It has been shown 
that trans-l-aminocyclopentyl-1,3-dicarboxylic acid (t- 
ACPD), selective agonist of metabotropic receptors 
depressed synaptic transmission in the hippocampus 
(Garaschuk et al., 1992; Goh & Musgave, 1993). Several
studies have suggested the involvement of NMDA and 
metabotropic receptors or both in long-lasting changes of 
neuronal activity (LTP and LTD) ( Kano and Kato, 1987; 
Aronidou and Teyler, 1991; Yang and Faber, 1991; Bashir & 
Col1ingridge, 1992; Dudek & Bear, 1992; Mulkey & Malenka, 
1992; Yang et al., 1994).
A variety of different protocols can be used to induce 
LTD including those which involve homosynaptic or 
heterosynaptic pathways. When LTD occurs at inputs whose
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activation contributes to the induction of modification, it
is known as homosynaptic LTD and when it shows itself at
inputs that had been inactive during induction it is 
referred as heterosynapt ic LTD. There are two ways to 
induce homosynaptic LTD: a) With high frequency stimulation 
in the neocortex, striatum and nucleus accumbens (Lovinger 
et al. , 1992; Walsh, 1993) b) With low frequency
stimulation in the CA1 region of the hippocampus (Bramham 
& Serbro, 1987; Artola & Singer, 1993; Linden, 1994).
GABA, is a major inhibitory neurotransmitter in the 
vertebrate central nervous system, and its receptors have 
been classified into at least two types (Sivilotti & 
Nistri, 1991). GABAg receptors induce inhibition of
transmitter release and hyperpolarization mediated by 
potassium channels, whereas GABAA receptors mediate a 
bicuculline-sensitive hyperpolarization. Binding to the 
chloride channel complex causes the opening of the channel 
and the influx of chloride ions into the neuron (Bormenn, 
1989). The influx of chloride ion makes the membrane 
potential of the postsynaptic cell more negative and 
usually induces an inhibitory state. The GABAA receptor is 
believed to be a heterooligomer of 4-5 receptor subunits 
that makes a central ionic pore and contains certain 
binding sites at least for GABA, picrotoxin, barbiturates,
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benzodiazepines and neurosteroids (Barnard et al. , 1987;
Delory & Olsen, 1992).
GABAa receptors mediate fast synaptic inhibition 
through the activation of receptor-linked chloride 
ionophores (Sivilotti & Nistri, 1991). Certain synthetic 
and endogenous steroids like alphaxalone and 5a-pregnan-3a- 
ol-20-one have been reported as positive modulators of GABAA 
receptor (Harrison & Simmonds, 1984; Turner & Simmonds, 
1989). They have been shown to have two distinct action on 
the GABAa receptor. At low concentrations, they potentiate 
GABAa action, while at higher concentrations they can 
directly open the chloride channel associated with the GABAA 
receptor (Majewska et al., 1989; Puia et al., 1991). It has 
been reported that in the hippocampus low frequency 
stimulation of Schaffer collateral fibres combined with 
brief pulses of GABA induced a massive depression of 
Schaffer collateral-CAl transmission (homosynaptic long­
term depression) (Yang et al., 1994).
The purpose of this part of project was to improve the 
understanding of the role of GABAA receptors in LTD and 
synaptic plasticity in the hippocampus in comparison with 
adenosine, which has been well studied as an inhibitory 
neuromodulator (Stone, 1991), and to compare the receptors
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involved with those defined in previous studies by 
examining the effect of the classical GABA^ receptor 
modulating steroids. In addition, the second object of this 
study was to determine the possible involvement of 
metabotropic and NMDA receptors in the LTD induced by the 
protocol which is presented in this chapter.
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5.2. Results
5.2.1. A new protocol for induction of LTD
Under normal experimental conditions, when the Schaffer 
collateral/ commissural fibres were stimulated at a 
frequency of 0.01 Hz, muscimol induced a concentration- 
dependent inhibition of the amplitude of the evoked
population potential (figure 5.1.). The maximum effect of 
muscimol was obtained at 10 pM. When used at concentrations 
of 0.1 to 5 pM, perfused for 10 minutes, this inhibition 
was readily reversible, and upon washing the slices
potential size was restored to control levels within 10 
minutes. When tested at the higher concentration of 10 pM, 
however, a stable, long-lasting depression of the 
population potential was obtained. The potential remained 
depressed, with no sign of recovery, for at least 20 
minutes after washing, the minimum period of washout
investigated. This is illustrated in figure 5.2. Whenever 
tested, the depression was found to persist for at least 60 
minutes after washout.
It was later realised that a similar long-lasting 
depression could be induced by using the lower
concentrations of muscimol applied for longer periods. 
Thus, a concentrations of 5 pM could reliably induce long- 
lasting depression if applied for 20 minutes (figure 5.3.).
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Figure 5.1. Concentration-response curves for the 
depression of orthodromically evoked CA1 population spikes 
(P.S.) by muscimol. Each point represents the mean ± 
s.e.m. for n = 5.
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Figure 5.2. Time course of the effect of adenosine (Ad) and 
muscimol (Muse) on orthodromically evoked CA1 population 
spikes. The duration of treatment was 10 minutes. Each 
point represents the mean ± s.e.m. for n = 4 experiments. 
Sample records of orthodromic potentials are shown above 
the graph.
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Figure 5.3. Time course of the effect of adenosine (Ad) and 
muscimol (Muse) on orthodromically evoked CA1 population 
spikes. The duration of treatment was 20 minutes. Each 
point represents the mean ± s.e.m. for n = 4 experiments. 
Sample records of orthodromic potentials are shown above 
the graph.
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5.2.2. Reversal of LTD
Once long-term depression had been established, and the 
inability of washing to reverse it confirmed, the 
potentials could be restored to control size by delivering 
stimuli at a rate of 1 Hz for 10 seconds (figure 
5.2.,5.3.,5.4.).
5.2.3. Adenosine and LTD
In order to draw a comparison with muscimol, a similar 
series of experiments was carried out using adenosine. At 
concentrations of 5, 10 and 20 pM, adenosine depressed the 
size of the population spikes, as reported on many previous 
occasions (by 24.88% ± 1.33, 48.75% ± 1.4 and 99.25% ± 0.48 
respectively; mean ± s.e.m, n = 4, P < 0.001). However, 
adenosine failed to induce any sign of long-term 
depression; potentials always recovered to control levels 
within 5 minutes of washout (figure 5.2.,5.3.). Even at a 
concentration of 50 pM adenosine was not able to induce LTD 
(figure 5.5.).
142
Po
pu
la
ti
on
 
Sp
ik
e 
(
20
C ontro l  Mus Wash Mus Wash
16
1 Hz12
8
4
0 L—  
- 3 0 -20 - 1 0 0 10 20 30 40 50 60
Time (min)
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5.2.4. Role of stimulation in induction of LTD
In view of the efficacy of 1 Hz stimulation to 
terminate LTD and restore potential size to control levels, 
experiments were also conducted to assess the importance of 
maintained stimulation for the induction of LTD by 
muscimol. In these experiments, the normal stimulation was 
turned off during the application of muscimol. This absence 
of synaptic activity did not modify the induction of LTD, 
as illustrated in figure 5.6. In order to confirm the 
involvement of GABAA receptors in the effect of muscimol, 
bicuculline methobromide was used as a receptor antagonist. 
When added to hippocampal slices, however, bicuculline can 
induce multiple epileptiform bursts of spikes which can 
complicate interpretation. In these experiments, therefore, 
LTD was induced by muscimol and bicuculline was then added 
into the perfusing medium. In each of 4 slices, bicuculline 
reversed the LTD within 2 minutes, and before the 
appearance of multiple population spikes (figure 5.7.).
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5.2.5. Neurosteroids and LTD
In order to assess the role of conventional GABAA 
receptors in the induction of LTD, without the need for 
inducing the neuronal hyperexcitability and spontaneous 
epileptiform bursting which results from the use of 
bicuculline or picrotoxin, two neurosteroids were used in 
an attempt to enhance the effect of activating GABAA 
receptors.
The natural steroid, 5a-pregnan-3a-ol-20-one and the 
steroidal anaesthetic agent alphaxalone were superfused 
over the slices at concentrations of 0.5 to 10 pM. Neither 
compound had any effect itself on population potentials at 
the lower concentrations (0.5 -1 pM) but at 5 pM or above 
both were able to depress potential size (chapter 4).
Even at the lower concentrations, however, both steroids 
proved able to potentiate the inhibitory activity of 
muscimol on population spikes; at 5 pM the effect of 
muscimol was increased almost 4-fold (chapter 4).
Both agents similarly potentiated the ability of muscimol 
to induce LTD. A normally ineffective concentration of 1 pM 
of the GABA agonist, applied for 10 minutes, for example, 
was able to induce LTD in the presence of only 1 pM
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alphaxalone (figure 5.8.) or 5a-pregnan-3a-ol-20-one 
(figure 5.9.). As for mscimol alone, increasing stimulation 
frequency to 1 Hz for 10 seconds was sufficient to reverse 
the LTD and restore potentials to their control size.
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Figure 5.8. Depression of orthodromically evoked CA1 
population spikes by muscimol, alpnaxalone and muscimol + 
alphaxalone. Each vertical bar represents the mean ± s.e.m. 
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5.2.6. Maintenance of LTD
When we induced LTD by application of muscimol 10 pM 
for 10 minutes, low concentrations of muscimol (0.5 and 1 
pM) , alphaxalone and 5a-pregnan-3a-ol-20-one 1 pM were 
superfused over the slices. Interestingly, muscimol 1 pM 
which is not able to induce LTD alone and positive 
modulators of GABAA like alphaxalone and 5a-pregnan-3a-ol- 
20-one in concentrations that can potentiate the inhibitory 
effect of muscimol, maintained the LTD induced by muscimol 
10 uM. Moreover, the delivering of 1 Hz stimulation did not 
reverse the LTD in this series of experiments. 
Nevertheless, a lower concentration than 1 pM of muscimol 
was not able to maintain the LTD induced by muscimol 10 pM 
(figure 5.10.,5.11.,5.12.).
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Figure 5.10. Time course effect of muscimol 10 pM (Muse) 
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5.2.7. Antagonists and agonists at glutamate receptors and 
LTD
To examine the possible involvement of glutamate 
receptors in the effect of muscimol, experiments were 
performed using the N-methyl-D-aspartate (NMDA) antagonist 
(±)-2-amino-5-phosphonopentanoic acid (2-AP5; 300 pM) , the 
mixed metabotropic and NMDA receptor antagonist (±)-2- 
amino-3-phosphonopropionic acid (2-AP3; 200 pM) and the
selective antagonist of metabotropic receptors L(+)-2- 
amino-3-phosphonopropionic acid [L( + )-AP3; 150 pM] . None of 
these compounds modified the ability of muscimol to induce 
LTD (figure 5.13.,5.14.,5.15 . ) . Equally, treatment of the 
slices with the non selective metabotropic receptor agonist 
quisqualic acid at 10 and 50 pM and the selective 
metabotropic receptor agonist (1S,3R)-ACPD 100 pM did not 
induce LTD whereas both agents showed inhibitory effects on 
the population spike size (figure 5. 16.,5.17.). In addition 
to this, kynurenic acid, a broad spectrum antagonist of 
NMDA and non NMDA receptors (100 and 200 pM) did not induce 
LTD but it prevented termination of LTD by stimulation at 
1 Hz (figure 5.18.).
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Figure 5.13. Time course of the effect of muscimol 10 yM 
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Figure 5.15. Time course of the effect of muscimol 10 pM 
(Mus) and L ( + )-2-amino-3-phosphonopropionic acid 150 pM 
[L (+)-AP3] on orthodromically evoked CA1 population spikes. 
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5.3. Discussion.
Long-term depression is an activity dependent form of 
synaptic plasticity that is accepted as being important in 
learning and memory since at the cellular level, memories 
are believed to be stored as long-term modifications in the 
strength of synaptic transmission. The hippocampus is 
probably involved in processes such as learning and memory 
and hippocampal slices are a convenient model for 
investigating synaptic plasticity.
The present results demonstrate that the application of 
a selective GABAA agonist to hippocampal slices can induce 
LTD of synaptically-evoked population potentials when 
stimulation was effected at a low frequency of 0.01 Hz. 
Increasing stimulation frequency to 1 Hz abolished the LTD. 
This stands in contrast to the work of Yang et al (Yang et 
al. , 1994) who observed that LTD could be induced while
stimulating at 1 Hz, but is in agreement with the work of 
other groups which have indicated that low frequency 
stimulation is more effective in inducing LTD in the 
hippocampus than in neocortex, striatum or nucleus 
accumbens (Bramham & Srebro, 1987; Artola & Singer, 1993; 
Lovinger et al. , 1993; Walsh, 1993; Linden, 1994). The most 
important difference between the protocol which is
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presented by this thesis and previous protocols to induce 
LTD is the fact that the LTD is induced by using 0.01 Hz 
stimulation and, increasing stimulation to 1 Hz, reversed 
the LTD whereas other groups induced LTD by using 1-5 Hz 
stimulation and their low frequencies to induce LTD (1-5 
Hz) is actually the frequency to reverse the LTD which is 
presented by this thesis (Braham and Srebro, 1987; Staulbi 
and Lynch, 1990). Indeed, in the present work it has been 
found that muscimol alone is effective in inducing LTD even 
in the absence of afferent stimulation. This would seem to 
rule out a possible mechanism for LTD which involves an 
interaction between GABAA receptors and a synaptically 
released agent or a second messenger molecule released from 
postsynaptic sites in response to a neurotransmitter.
In the present experiments the apparent desensitisation 
reported previously during prolonged applications of GABA 
or GABAa agonists was not observed (Forsch et al., 1992; 
Celentano & Wong, 1994).
It has also been found that the ability of muscimol to 
produce LTD is dependent on the concentration of muscimol 
used, and on the duration of application: lower
concentrations can be effective if in contact with the 
slices for a longer period. This would be consistent with
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the accumulation of a secondary compound postsynaptically 
or in the extracellular space, and which must attain a 
critical level in order to establish LTD.
The application of agonists at GABAg receptors has been 
found to induce LTD. Activation of this receptor population 
is believed to act via the opening of potassium channels 
(Deisz et al., 1993), whereas GABAA receptors are effective 
mainly as a result of operating chloride conductances 
(Sivilotti & Nistri, 1991). It is of particular interest, 
therefore, that adenosine, which is also capable of 
depressing neuronal excitability partly via the opening of 
chloride channels (Mager et al. , 1990,1995), was not able 
to induce LTD. Adenosine proved ineffective at 
concentrations which were able to substantially inhibit 
normal orthodromic potentials. This may suggest that GABAA 
or GABAg receptor activation involves some form of 
transduction system which is not activated indiscriminately 
by any neuronal inhibitory agent. Furthermore, the results 
are consistent with previous reports that adenosine 
operated chloride channels differ from GABAA activated 
chloride channels (Mager et al., 1990,1995; Chapter 3 and 
4 of this thesis).
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The latter section of the present results represent an 
attempt to determine whether the GABA^ receptors causing LTD 
show the same pharmacological properties as GABA receptors 
described previously on hippocampal neurones. Several 
neurosteroids which are synthesized in glial cells are 
known to modulate GABAA receptor properties via an 
allosteric site. These steroids at high concentrations, 
like barbiturates but unlike benzodiazepines, can open 
chloride channels. The steroidal anaesthetic alphaxalone, 
and the related compound 5-a-pregnan-3a-ol-20-one had no 
effect themselves upon population spike amplitude at low 
micromolar concentrations, whereas they were both able, at 
these same concentrations, to potentiate significantly the 
depressant activity of muscimol on evoked spikes. At the 
higher concentrations tested here, 5 and 10 uM, both 
steroids did have a direct depressant effect on evoked 
potentials, consistent with evidence that at these levels 
they can directly open chloride channels (Harrison & 
Simmonds, 1984; Turner & Simmonds, 1989; Puia et al. , 
1991). When examined on LTD, both the steroids were able 
to potentiate the effects of muscimol to the extent that 
concentrations which had been insufficient to induce LTD 
did so in the presence of the steroids. As with the LTD 
observed normally in response to muscimol alone, the LTD
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produced by 1 uM muscimol plus steroids was also reversed 
by increasing the stimulation frequency to 1 Hz.
One of the interesting findings of this study was that 
the muscimol induced LTD showed features potentially 
important in a negative memory mechanism. Thus after 
application of 10 pM muscimol had induced the LTD, 
superfusion of either muscimol 1 pM or alphaxalone and 5a- 
pregnan-3a-ol-20-one 1 pM, which do not show any effect 
alone, were able to maintain the LTD. Moreover, delivering 
1 Hz stimuli failed to restore the potentials to control 
size during the application of muscimol 1 pM and 
neurosteroids.
The significance of such a phenomenon for the whole 
animal are profound, since they imply that after a simple, 
brief exposure to a stimulus sufficient to raise inhibitory 
synaptic activity to a level which can induce a forgetting 
process, that loss of memory could be maintained by very 
low levels of tonic inhibition. Furthermore, and possibly 
even more significantly, the inhibition can be maintained 
by hormonal means-low levels of neurosteroids - as well as 
or instead of, synaptic inhibition.
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The results thus greatly strengthen the view that 
forgetting is a physiological process amenable to subtle 
pharmacological manipulation, and raise the possibility 
that drugs capable of preventing forgetting may be as 
feasible as drugs facilitating learning.
The latter section of this study indicates that 
bicuculline is able to reverse the LTD induced by muscimol 
and our result is in contrast to the work of Yang et al 
(Yang et al. , 1994) who reported bicuculline could not
block LTD induced by muscimol. However, the frequency 
dependence of the LTD studied by Yang et al. (1994) differs 
from that of present study. This may suggest that different 
forms of LTD may occur in the hippocampus, involving 
distinct populations of receptors. Nevertheless, most 
recently, Thiels’ et al reported a bicuculline-sensitive 
LTD that is in line with the result of this study (Thiels 
et al., 1994).
The excitatory amino acid glutamate is a major 
excitatory transmitter within the central nervous system 
(CNS)(Col1ingridge and Lester, 1989). The response to 
glutamate is mediated by activation of multiple glutamate 
receptor subtypes and leads to either an ionotropic or a 
metabotropic response. Of particular interest in recent
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years has been the investigation of the role of glutamate 
in synaptic efficacy. Several groups have recently reported 
on factors affecting the induction of LTD, although no 
consensus has emerged as to the minimum conditions 
necessary or sufficient for the phenomenon. Some proposals 
include the involvement of NMDA receptors and glutamate 
metabotropic receptors (or both) in LTD (Kano and Kato, 
1987; Aroniadou and Teyler, 1991; Yang and Faber, 1991; 
Yang et al. , 1994). One objective of this study was to
determine the possible involvement of glutamate receptors 
in the protocol which was presented by this thesis. Failure 
of this study to induce LTD or even short-term depression 
(STD) with quisqualic acid and (1S,3R)-ACPD argues against 
such a role in the hippocampus. Furthermore, the failure of 
the NMDA receptor antagonist 2-AP5, the mixed 
NMDA/metabotropic antagonist 2-AP3 and selective 
metabotropic antagonist L(+)-AP3 to modify LTD formation 
exclude a role of either of these receptor populations in 
GABAa induced LTD. It is postulated that the involvement of 
NMDA and metabotropic receptors in previous reports is due 
to the use of stimulation frequencies at least 100 times 
higher (1-5 Hz) than the frequency of stimulation which is 
used in this study (0.01 Hz) (Staubli and Lynch, 1990; Yang 
et al., 1994). On the other hand, kynurenic acid, a potent 
glutamate receptor antagonist, could prevent the reversal
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of the LTD that is induced by increasing stimulation to 1 
Hz. The results suggest that increased stimulation 
frequency reverses muscimol induced LTD as a result of the 
release of excitatory amino acids, such as glutamate.
In summary, the present study has presented a new 
protocol for inducing LTD through activation of GABAA 
receptors that can depress synaptic excitability in the 
hippocampal slice. In addition, it is reported that this 
ability is not shared by adenosine, but it is potentiated 
by neurosteroids known to enhance the binding and 
postsynaptic hyperpolarisation induced by classical GABAA 
receptors. Moreover, the lack of involvement of glutamate 
receptors in producing LTD, suggest that activation of GABAA 
receptors alone is sufficient to induce LTD and confirm the 
involvement of classical GABAA receptors in the protocol 
which has been presented by this thesis. This indicates 
that the phenomenon described in the present study 
represents a novel type of long-term synaptic inhibition.
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Role of calcium in induction and 
reversal of muscimol-induced LTD
6.1. Introduction
It is believed that the hippocampus plays a prominent 
role in learning and memory processes (Eichenbaum et al. , 
1994). Long-term depression (LTD) is an activity dependent 
decrease in synaptic efficacy that, with its counterpart, 
long-term potentiation (LTP), has been considered to be 
critical for neuronal plasticity (Hebb, 1949; Nicol et al., 
1988; Linden, 1994). Most of the work to date on LTD has 
been performed on the cerebellar cortex, nucleus accumbens, 
striatum, neocortex and CA1 region of the hippocampus (Levy 
and Steward, 1979; Ekerot and Kano, 1985; Ito, 1988; Kimura 
et al. , 1989; Stanton and Sejnowski, 1989; Calabresi et
al., 1992; Pennartz et al., 1993).
Several different protocols for the induction of LTD 
have been reported in the cerebellum and hippocampus which 
may be categorised as homosynaptic, heterosynaptic and 
associative LTD (Braham and srebro, 1987; Artola and 
Singer, 1993; Lovinger, 1993; Walsh, 1993; Linden, 1994). 
Although the mechanisms for the induction of LTP are 
fairly well established, the mechanisms underlying the 
induction of LTD have remained unresolved (Bliss and Lomo, 
1973; Stanton and Sejnowski, 1989; Yang and Faber, 1991; 
Bliss and Col1ingridge, 1993).
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Most excitatory synapses in the central nervous system 
use glutamate as a neurotransmitter. Glutamate receptors 
are classified in two general categories 1: Ionotropic
receptors that are associated with ion channel activation 
and are affected by N-methyl-D-aspartate and kainic acid 2: 
metabotropic receptors that are coupled to G proteins and 
modulate the intracellular second messenger systems 
(Col1ingridge and Laster, 1989; Monaghan et al. , 1989;
Schoepp et al., 1990; Miller, 1991; Nakanishi, 1992).
NMDA and metabotropic glutamate receptors have been
reported to play a critical role in the induction of 
different forms of LTD (Kano and Kato, 1987; Aroniadou and 
Teyler, 1991; Yang and Faber, 1991; Bashir and 
Col1ingridge, 1992; Dudek and Bear, 1992; Garaschuk et al. ,
1992; Mulkey and Malenka, 1992; Goh and Musgave, 1993; Yang
et al., 1994). It has been shown that the various forms of
plasticity (LTP and LTD) described to date need NMDA
2+receptor-gated Ca influx (Christi et al. , 1994; Debanne
and Thompson, 1994). This probably reflects the fact that 
the state of LTD or LTP depends on the level of
phosphorylation of some undefined substrate. Small
2+increases in intracellular Ca decreases the level of
2+phosphorylation by increasing Ca -dependent protein
phosphatase activity, whereas larger increases of calcium
2+are associated with phosphorylation by enhancing Ca
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dependent protein Kinase: in general kinases need larger
2+increases of Ca for activation than phosphatases.Christ1  
et al., 1994; Debanne and Thompson, 1994; Hirano et al. ,
1994) .
Y-aminobutyric acid (GABA) is the most important 
inhibitory neurotransmitter in the CNS (Sivilloti and 
Nistri, 1991). Inhibitory processes are important for the 
stability and control of neuronal firing. These processes 
are mediated by GABA. Three types of pharmacologically and 
physiologically distinct GABA receptors have been reported. 
Activation of bicuculline-sensitive GABA type A (GABAA) 
receptors induces the opening of ion channels permeable to
Cl’. The baclofen-sensitive GABA type B (GABAg) receptors
1 2 +
are coupled to K or Ca channels via G proteins. Most 
recently GABA type C (GABA^ ,) receptors have been described 
that couple to Cl" channels but they are insensitive to 
bicuculline and baclofen (Barnard et al. , 1987; Bormann,
1989; Sivilloti and Nistri, 1991; Deisz et al., 1993).
We have reported a novel type of LTD induced by 
muscimol (chapter 5), a GABAA agonist, that is reversed by 
the GABAa antagonist bicuculline and potentiated by 
neurosteroids such as alphaxalone and 5a-pregnan-3a-ol-20- 
one which are positive modulators of GABAA receptors
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(Harrison and Simmonds, 1984; Magewska and Harrison, 1988; 
Peters et al., 1988; Turner and Simmonds, 1989; Puia et
al., 1991). It has also been reported that NMDA, non NMDA 
and metabotropic glutamate receptors are not involved in 
the induction of this type of LTD (chapter 5). The 
activation of synapses is not necessary for the induction 
of this LTD since the long-lasting depression could be 
induced when there was no stimulation during perfusion of 
muscimol. This type of LTD is induced at low frequency ( 
0.01 Hz) and is reversed by delivering stimulation at a 
frequency of 1 Hz for 10 seconds. Besides the lack of 
involvement of glutamate receptors, this reversal 
represents another major difference between muscimol- 
induced LTD and that reported previously, since other 
groups actually use stimulation at 1-5 Hz to induce 
glutamate-dependent LTD (Linden, 1994; Yang et al., 1994).
The aims of this part of project were twofold. The 
first objective was to investigate the possible role of 
calcium in the induction of glutamate independent LTD. The 
second objective was to determine the mechanism of reversal 
of the LTD by stimulation.
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6.2. Results
6.2.1. Muscimol-induced LTD
Once stable hippocampal population potentials had been 
obtained at a frequency of 0.01 Hz, the addition of the 
GABAa agonist muscimol at concentration of 10 pM for 10 
minutes induced a stable long-lasting depression of 
population potentials. The LTD induced by muscimol was 
concentration and time dependent as described in chapter 5 
(figure 6.1.,6.2.,6.3.). There was no sign of recovery 
during washout with drug-free ACSF for at least 60 minutes. 
The activation of synapses was not necessary for the 
induction of LTD, as the depression could still be obtained 
when stimulation was turned off during the application of 
muscimol.
Once established, LTD persisted until the frequency of 
stimulation of the stratum radiatum was increased to 1 Hz 
for 10 seconds when potential size returned immediately to 
the control level (figure 6.1.,6.2.,6.3.).
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Figure 6.1. Depression of orthodromically evoked CA1 
population spikes by adenosine and muscimol. The duration 
of treatment was 10 minutes. Treatment with adenosine or 
muscimol at 5 uM or less produced reversible depression of 
the population potentials. Muscimol at 10 pM produced long- 
lasting depression which was not reversed by washing but 
which was reversed by stimulation at 1 Hz. Each vertical 
bar represents the mean ± s.e.m. for n = 4 experiments. A 
paired Student’s t test was employed to determine the 
significance level (m P < 0.001).
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Figure 6.3. Depression of orthoaromically evoked CA1 
population spikes by adenosine and muscimol. The duration 
of treatment was 20 minutes. Each vertical bar represents 
the mean ± s.e.m. for n=4 experiments. A paired Student’s 
t test was employed to determine the significance level 
(m P<0.001) .
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6.2.2. Calcium-free medium and LTD
As expected from the synaptic nature of the evoked 
responses in CA1, superfusion with calcium-free medium led 
to a rapid loss of responses, but this recovered with a 
rapid time course when calcium was re-introduced (figure 
6.4.). If slices were superfused with calcium-free medium 
until the CA1 evoked responses had disappeared and muscimol 
10 pM was then perfused for 10 minutes, as in our earlier 
protocol, the re-introduction of calcium failed to restore 
potential size. This depression of potentials appeared to 
be exactly similar to that described earlier, since 
stimulation at a rate of 1 Hz for 10 seconds was sufficient 
to restore potential size to control levels (figure 6.4.).
6.2.3. The role of NMDA and non-NMDA receptor activation in 
the reversal of muscimol-induced LTD
In view of the efficacy of 1 Hz stimulation to 
terminate LTD and restore potential size to control levels, 
experiments were carried out to determine the possible 
involvement of glutamate receptors in the reversal of LTD 
induced by muscimol. Experiments were performed using 
Kainic acid 5 uM and NMDA 5 uM. At these concentrations
both kainic acid (figure 6.5.) and NMDA (figure 6.6.)
induced a small increase in the size of the CA1 potentials 
when applied for 10 and 5 minutes respectively. Higher 
concentrations produced overdepolarisation and a loss of 
evoked responses. If LTD were induced by superfusion with 
muscimol at 10 pM for 10 minutes both amino acid receptor 
agonists proved able to reverse the depression (figure 
6.5.,6.6.). Two additional points may be noted from the 
figures. Firstly kainate proved able to reverse muscimol- 
induced LTD more rapidly than did NMDA, although kainate 
alone produced a larger enhancement of normal evoked 
potential size than did NMDA. The more rapid reversal of 
LTD may therefore simply reflect a greater degree of 
depolarisation of the slices. Secondly, it should be noted 
that the prior superfusion with kainate or NMDA did not 
prevent or modify in any way the subsequent ability of 
muscimol to induce LTD.
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6.2.4. High potassium and veratrine and reversal of 
muscimol-induced LTD
In order to determine the mechanism by which muscimol- 
induced LTD was being reversed, slices were depolarised by 
superfusion with a medium containing a 5 mM increment of 
potassium chloride or with veratrine. In each slice 
examined, raised potassium was tested alone before muscimol 
application. Raising the potassium level by 5 mM itself 
increased field potential size (figure 6.7.). After washing 
to restore potential size to normal, LTD was induced by 
muscimol. This was reversed immediately by stimulation at 
1 Hz or over the 5 minutes period of an application of 
raised potassium (figure 6.7.). Similarly, superfusion with 
veratrine at 4 uM also reversed muscimol-induced LTD, 
though the time course of this was slower than with 
potassium or excitatory amino acid agonists (figure 6 .8 .). 
Indeed full restoration of response size was not achieved 
until 2 0  minutes after beginning the washout of veratrine.
In a modification of the previous experiment, LTD was 
induced by muscimol but washout was performed using a 
calcium-free solution (figure 6.9.). The potassium 
concentration of the medium was then raised while still in 
calcium-free medium. When normal ACSF was introduced
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subsequent to this, the LTD was found to be reversed, with 
evoked potentials regaining their original size within 1 0  
minutes (figure 6.9.)-
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6.2.5. High calcium or a calcium ionophore and reversal of 
muscimol-induced LTD
Raising the level of calcium in the superfusion medium 
to a total 10 mM increased the size of control evoked 
potentials to an extent comparable with elevated potassium, 
NMDA or kainic acid application, but did not prove able to 
reverse muscimol-induced LTD (figure 6.10.). Electrical 
stimlation of the stratum radiatum at 1 Hz however, 
produced its usual immediate reversal (figure 6.10.). On 
the other hand, superfusion with the calcium ionophore 
A23187 at 10 pM did reverse LTD, albeit with a relatively 
slow course similar to that observed with veratrine (figure 
6 . 1 1. ) .
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6.3. Discussion
There is increasing interest in the phenomenon! of LTD 
since, together with LTP, it represents a potential 
information storage mechanism in the hippocampus. A variety 
of protocols have been reported for producing LTD but these 
invariably seem to involve metabotropic or NMDA receptors 
in the induction of LTD (Aroniadou and Teyler, 1991; Yang 
and Faber, 1991; Lovinger et al., 1993). As it was
described in chapter 5, there is a lack of involvement of 
either NMDA or metabotropic glutamate receptors in the 
induction of LTD by the protocol which is presented in this 
thesis, using the GABAA agonist muscimol. Another 
distinction between this protocol and other methods for 
producing LTD is that muscimol induced LTD can be 
demonstrated using a stimulation frequency of 0.01 Hz and 
indeed, even in the absence of stimulation. Other groups 
have induced LTD in the hippocampus by stimulating at a 
frequency of 1-5 Hz (Braham and Srebro, 1987; Staubli and 
Lynch, 1990; Yang et al., 1994), whereas muscimol-induced 
LTD is reversed at this frequency.
Several reports have confirmed the crucial role of 
calcium in induction of LTD or LTP (Hirano et al. , 1994;
yang et al., 1994). They have indicated that the state of
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LTD or LTP depends on the balance between phosphorylation 
and dephosphorylation. Small amounts of calcium activate 
phosphatase enzymes and it has been shown that this leads 
to LTD, whereas the release of larger amount of calcium 
activates phosphorylation that can induce LTP (Christie et 
al. , 1994; Debanne and Thompson, 1994; Hirano et al. ,
1994) .
The object of this part of the project was to determine 
whether the novel form of muscimol-induced, glutamate- 
independent LTD was dependent upon a movement of calcium 
ions.
The results indicate that these mechanisms are unlikely 
to pertain to the muscimol-induced form of LTD, since the 
omission of calcium ions did not prevent the establishment 
of LTD by muscimol perfused during the calcium-free period. 
Taken together with previous evidence (chapter 5) for the 
lack of involvement of ionotropic or metabotropic glutamate 
receptors in muscimol LTD, this lack of dependence upon 
calcium emphasises further the novelty of this form of 
synaptic depression.
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It was also of interest to examine the mechanisms of 
reversal of LTD since the frequency of orthodromic 
stimulation which reverses this depression (1 Hz) is 
similar to the frequency used by several other groups to 
induce (glutamate-dependent) LTD. Since it was shown that 
reversal of LTD can be prevented by the non-select ive 
glutamate receptor antagonist kynurenic acid (chapter 5), 
it seemed likely that activation of NMDA or non-NMDA 
receptors would be implicated in the reversal. In fact, 
superfusion with either NMDA or kainic acid, at 
concentrations which had small excitatory effects on the 
pyramidal cells but which were below those needed to 
overdepolarise them, both induced reversal of LTD.
This lack of receptor selectivity for reversal, 
however, argued that a common feature, such as 
depolarisation per se, might be responsible for the 
reversal, rather than a receptor specific mechanism.
It is known that activation of both NMDA and kainate 
receptors is associated with the influx of calcium ions 
into neurones, but this is probably not the mechanism of 
LTD reversal here, since raising external calcium levels to 
10 mM did not prove able to reverse LTD once established. 
The simple elevation of calcium levels does not, however,
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entirely eliminate the possibility that reversal by the 
amino acid agonists is the result of depolarisation of the 
neurones which may (or may not) act via a larger, secondary 
depolarisation-induced release of intracellular calcium.
In order to test these possibilities, two other 
depolarising stimuli were examined, potassium and veratrine 
a sodium channels opener (Catteral, 1980; Leibowitz et al., 
1986; Barnes and Hille, 1988). Both procedures should 
depolarise neurones with an influx of sodium ions, a 
consequent depolarisation-induced release of intracellular 
calcium, and an accompanying influx of calcium through 
voltage-dependent channels. Both stimuli were indeed able 
to reverse LTD, and subsequent testing of potassium in 
calcium-free medium was also able to do so. These results 
are thus consistent with the failure to reverse LTD by 10 
mM calcium alone and reinforce the view that depolarisation 
induced calcium influx is not responsible for the reversal 
of LTD. Reversal could be obtained, however, by the calcium 
ionophore A23187, supporting the possibility that 
intracellular calcium is needed for the reversal of LTD.
Another possibility is that this effect of calcium 
ionophore is due to dephosphorylation of GABAA receptors 
that decreases GABAA ability to induce LTD. This suggestion
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is in line with previous reports that indicate an increase 
of intracellular calcium decreases GABAA efficacy (Chen et 
al. , 1990; Markram and Segal, 1991; Feigenspan and Bormann, 
1994; Gyenes et al., 1994; Martina et al., 1994).
Overall the present data indicate that neither the 
induction of LTD, nor its reversal, require extracellular 
calcium. The reversal, however, may involve a rise of 
intracellular calcium levels. This is probably calcium 
released from intracellular storage sites in response to 
the sodium influx which accompanies the depolarisation of 
neurones, whether caused by glutamate receptor activation, 
high potassium or veratrine, but which can be mimicked by 
the action of calcium ionophore A23187.
197
General Discussion
7. General discussion
40 years have passed since Holton and Holton suggested 
that a purine compound could have a role in 
neurotransmission. Since then the role of purines in the 
brain has been well described and adenosine is now widely 
accepted as the major inhibitory neuromodulator in the 
central nervous system besides GABA. However, no 
adenosinergic drugs are used clinically for treatment of 
CNS disorders. One important limitation for the use of
adenosine in the CNS is that we do not actually know the 
effect of adenosine on ion fluxes. Although the role of 
adenosine on potassium channels and potassium currents is 
relatively well described, the role of adenosine on calcium 
and, in particular, chloride channels is still a matter of 
controversy. By contrast, GABA, as an important and 
abundant inhibitory transmitter in the CNS, is well 
described. It has been shown that in the hippocampus, 
evoked fast inhibitory postsynaptic currents are mediated 
by a GABAa receptor-activated Cl" conductance.
Chapters 3 and 4 of this thesis have looked at the
possible role of adenosine on the chloride channels and the
interaction between adenosine and muscimol as a global
tonic inhibitory system in the hippocampus. The results
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indicated that adenosine, besides affecting potassium and 
calcium channels, also acts on chloride channels. In 
addition to this, it has been shown that there is a tonic 
positive interaction between adenosine and the GABAA 
receptor at the level of chloride channels. It has been 
reported that impairment of fast inhibitory postsynaptic 
currents can lead to pathological conditions such as the 
generation of epileptic discharge and excitotoxity. Several 
agents which are used clinically such as anticonvulsant, 
antiepileptic, sedative/hypnotic and anxiolytic drugs, 
exert their effects at the GABAa receptor-chloride ionophore 
complex. Moreover, it has been reported that adenosine 
antagonists, such as caffeine or theophylline, can induce 
seizures and can block the behavioural effects of 
benzodiazepines. On the other hand, adenosine and its 
analogues can prevent seizures in vivo or in human models.
The Positive interaction between adenosine and the 
GABAa receptor at the level of chloride channels suggests 
that the idea of application of adenosine derivatives or in 
combination with a GABAA agonist or a positive modulator of 
GABAa receptors such as neurosteroids may be useful in the 
treatment of CNS disorders.
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There is considerable evidence which suggests that the 
hippocampus plays a crucial role in certain forms of 
learning and memory. It has been reported that virtually 
all aspects of memory processing by the hippocampal system 
can be referred to its function as a temporary memory 
store. Moreover, hippocampal lesions induce retrograde and 
anterograde amnesia. In view of the predominant role of the 
hippocampus in learning and memory disorders and the 
increase of these in the last decades of life, several 
investigations have been centred on the hippocampal system 
and its pathophysiology.
Hippocampal synaptic plasticity (long-term potentiation 
and depression) involves long-lasting changes of the 
efficacy of information processing at the synaptic site. 
There is increasing interest in the phenomenon of LTD that, 
together with its allied phenomenon, LTP, is an important 
information storage mechanism in the CNS involving plastic 
changes of synaptic function lasting for several hours.
Chapters 5 and 6  of this thesis have been devoted to the 
role of adenosine and GABAa receptors in this synaptic 
plasticity. The results presented that this thesis 
described a novel type of LTD which is induced by muscimol, 
a GABAa agonist. The main point of novelty of muscimol
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induced LTD is that the induction of muscimol induced 
LTD is calcium and glutamate independent. Furthermore, 
bicuculline as a GABAA antagonist reverses muscimol-induced 
LTD. On the other hand, neurosteroids which are positive 
modulators of GABAA receptors can potentiate the ability of 
muscimol in the induction of LTD. Another major finding 
of this thesis is that muscimol induced LTD can be produced 
in the absence of stimulation. As the classification of LTD 
is based on the stimulation of afferent pathways, this 
phenomenon emphasised the novelty of muscimol-induced LTD. 
Furthermore, a potentially important concept clinically 
rises from the maintenance of the LTD by neurosteroids. If 
neurosteroids are able to maintain LTD induced by a 
release of GABA that then triggers the forgetting process, 
then agents which decrease the effects of neurosteroids or 
negative modulators of GABAA receptors, may be able to 
reverse LTD to a normal state and thus help to reverse or 
prevent the forgetting process.
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